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General Abstract 
Tuberculosis is caused by Mycobacterium tuberculosis. The emergence of drug-resistant 
strains of this organism has become a global public health problem. In the continuing search 
for effective treatment, polyherbal medicines offer a great hope in the development of 
alternative drugs for the treatment of tuberculosis. The use of herbal formulations for 
therapeutic purposes has significantly increased in the developed and developing countries 
because of their curative property, less toxicity and minimal side effects. However, there is 
little information on their safety and effectiveness in the literature. To address this, 
polyherbal medicines used for the treatment of tuberculosis in the Eastern Cape Province of 
South Africa were evaluated.  
Ethno-medicinal survey was conducted through semi-structured questionnaires coupled with 
informal conversations with the herbal sellers in five communities in the study area. Bacterial 
and fungal DNA was extracted from the polyherbal medicines purchased. A fragment of the 
bacterial 16S rRNA gene and internal transcribed spacer region of the fungal rRNA operon 
were amplified with universal primers 27F and 518R, and ITS1 and ITS4 respectively. 
Following standard procedures, the amplicons were finally run on Illumina’s MiSeq platform. 
Furthermore, the remedies were screened against Mycobacterium tuberculosis H37Rv using 
Middlebrook 7H9 media and MGIT BACTEC 960 system. Agar dilution method was used to 
determine the minimum inhibitory concentration (MIC) of the remedies against eight bacteria 
and three fungi isolates. The herbal preparations were assayed for their toxicity using 
hatchability success and larval mortality of Artemia salina Leach. Finally, their nutritive 
properties were analysed using an inductively coupled plasma optical emission spectrometer 
for mineral analysis while the vitamins were determined using standardized methods. 
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A total of nine polyherbal preparations were collected. The herbs used for the preparation of 
these remedies belong to 20 families. Apiaceae [5(25%)] was the most prominent plant 
family used, followed by Liliaceae [4(20%)], Strychnaceae [4(20%)], Rutaceae [4(20%)] and 
Hypoxidaceae [3(15%)]. The two most frequently used plants were Allium sativum L. 
(Liliaceae) and Strychnos decussata (Pappe) Gilg. (Strychnaceae). Rhizomes was the most 
common parts used, followed by the roots and barks. The herbal medicines were prepared 
mainly by infusion and decoction. 
The presences of pathogenic and non-pathogenic bacteria were identified in the polyherbal 
medicines. Generally, the most common bacteria identified from the samples were Bacillus 
sp., Enterobacter sp., Klebsiella sp., Rahnella sp., Paenibacillus sp., Clostridium sp. and 
Pantoea sp. The predominant mycoflora obtained belongs to different genera or species of 
fungi; these include Alternaria, Candida, Ramularia, Cladosporium, Penicillium, Aspergillus 
and Malassezia.  
The susceptibility testing revealed that all the remedies contain anti-tubercular activity 
against M. tuberculosis H37Rv at concentrations below 50 ug/ml. Seven of the polyherbal 
preparations showed activity at concentrations below 25 ug/ml. The MIC values exhibited 
inhibitory activity at 1.562 µg/ml. However, isoniazid showed more inhibitory activity 
against M. tuberculosis at 0.05 µg/ml when compared to the polyherbal remedies.  
The inhibitory activity of the polyherbal medicines based on the overall MIC revealed that 
Hogsback first site (HBfs) and Fort Beaufort (FB) remedies were the most active remedies 
against the bacterial isolates at the concentration of 2.5 mg/mL. Among the nine herbal 
formulations, only King Williams Town site A (KWTa) remedy showed activity against 
Aspergillus niger and Aspergillus fumigatus with the MIC valve of 2.5 mg/mL. While King 
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Williams Town site C (KWTc) and Hogsback third site (HBts) had the highest activity at 
1.25 mg/mL against Candida albicans, the remaining remedies were active at 2.5 mg/mL. 
The percentage hatchability of 44.42%, 42.96% and 39.70% were observed in A. salina cysts 
incubated with herbal preparations from KWTa, HBfs and HBts respectively. The hatching 
success of the cysts in these remedies was significantly higher than the positive control 
(nystatin) and the negative control (sea water) at p < 0.05. The mortality of A. salina nauplii 
incubated in Alice (AL), King Williams Town site B (KWTb) and KWTc remedies were 
significantly higher than when larvae were incubated in both controls. Based on Meyer’s 
index, the LD50 of each polyherbal medicine was between 2.9 and 4.0 mg/ml, the LD50 values 
greater than 1 mg/ml, an indication that they are not toxic.  
The polyherbal preparations were found to be rich in vitamins and mineral nutrients. Calcium 
was the highest macronutrient detected while the lowest nutrient was phosphorus. Iron was 
the highest micronutrient in the majority of the polyherbal preparations while the lowest 
value was recorded for copper. Vitamin C was absent in the herbal preparations while 
vitamin A and E were detected.  
This study provides significant ethno-medicinal information on polyherbal medicines used 
for the treatment of TB in the study area. The presence of the identified bacteria and fungi in 
the herbal formulations is a cause for concern. However, the ability of the remedies to 
possess activity against Mycobacterium tuberculosis and other pathogenic microorganisms 
associated with tuberculosis infection makes them potential sources of new antimycobacterial 
agents. Also, they are rich sources of mineral nutrients, and  are as well non-toxic, thus, they 
are safe for consumption. In view of their anti-tubercular properties, this study has provided a 
better understanding of the reasons why TB-patients make use of these polyherbal 
formulations. Also, the study supports the folkloric use of polyherbal medicines in the 
treatment of tuberculosis in the Eastern Cape Province, South Africa.  
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1.0 Introduction   
1.1.0 Etiology and mode of transmission of tuberculosis 
Tuberculosis (TB) is a contagious chronic bacterial infection caused by a group of closely 
related bacterial species called Mycobacterium tuberculosis complex. M. tuberculosis is the 
main cause of TB in humans while other members of the complex include M. bovis, M. 
canetti, M. microti and M. africanum. However, M. microti is not known to cause TB in 
humans; also infection with M. africanum is very rare, while M. bovis is the main cause of 
tuberculosis in other animal species (Sandhu, 2011). Mycobacterium tuberculosis is a rod-
shaped, aerobic and small slow-growing bacterium that lives only in humans. This disease is 
mainly transmitted via direct exposure to Tubercle bacilli in airborne droplets from coughing 
or sneezing of individuals living with the active respiratory disease (Narwadiya et al., 2011). 
M. tuberculosis mainly affects the lungs thereby causing lung tuberculosis called pulmonary 
tuberculosis or other parts of the body thus leading to extra-pulmonary tuberculosis (Sharma 
and Mohan, 2004). The common symptoms of active tuberculosis include cough with sputum 
and blood, chest pains, poor appetite, weakness, weight loss, fever and night sweats. The 
immunological life cycle of TB is shown in Figure 1.1. 
 
Figure 1.1: Stages in the immunological life cycle of tuberculosis (Michael, 2013) 
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1.1.1 Current status of tuberculosis 
Tuberculosis is a worldwide pandemic and the leading cause of mortality among people 
infected with human immunodeficiency virus (HIV) in the developing countries. TB has been 
reported to be among the top ten causes of death worldwide, ranking above HIV/AIDS as the 
leading cause of death among the infectious diseases (WHO, 2016). It has become a major 
public health concern globally with over 2 billion people infected, 10.4 million cases, and 1.8 
million deaths in 2015 (Baldwin et al., 2015). The largest number of new TB cases occurred 
in four Asian countries including India, Indonesia, China and Pakistan with 61% of new 
cases. This was followed by two African countries namely Nigeria and South Africa, with 
26% of new cases (WHO, 2016). One-third of the world’s population have been infected with 
latent tuberculosis; the resurgence of this disease has been attributed to the rise in HIV cases 
with 13% of mortalities amongst acquired immune deficiency syndrome (AIDS) patients 
(WHO, 2004; Anyangwe et al., 2006). In some countries in sub-Saharan Africa, about 75% 
of TB patients have been found to be HIV positive; and over 95% prevalence of TB deaths 
occurred in developing countries (Van Lettow et al., 2003) 
South Africa is one of the six countries with the highest burden of TB; and the incidence rate 
has increased by 400% over the past 15 years most especially among people living with HIV 
(Lall and Meyer, 1999; Green et al., 2010). It was estimated that about 80% of South African 
population is infected with M. tuberculosis with 88% prevalence of latent TB among 30-39 
years old (TBFACTS, 2015). TB has continued to be the leading cause of death in South 
Africa (Statistics South Africa, 2013). The WHO statistics gave an estimated incidence of 
500,000 cases of active TB in 2011. This implies that about 1% of 50 million South Africans 
contacted active TB diseases each year (Annual Performance Plan, 2012). Out of these cases, 
WHO estimated that about 330,000 (66%) people have both HIV and TB infection; but the 
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South African Department of Health revealed that 73% of TB patients are HIV positive 
(Annual Performance Plan, 2012).  
 
1.1.2 Treatment of tuberculosis and mechanism of action of TB-drugs 
Tuberculosis is a curable and preventable disease. The current treatment regimens comprised 
the combination of at least four drugs over a period of six months. These drugs include 
isoniazid, rifampicin, pyrazinamide and ethambutol (Duncan and Sacchettini, 2000; Zhang 
and Yew, 2009). In order to achieve effective cure rate, WHO recommended 2 months of 
intensive phase of daily administration of isoniazid, rifampicin, pyrazinamide and 
ethambutol. This is followed by 4 months continuous phase of daily use isoniazid and 
rifampicin (WHO, 2010). Based on mechanism of action as shown in Figure 1.2, tuberculosis 
drugs can be classified as inhibitors of bacterial protein synthesis (aminoglycosides), electron 
transport across the bacterial membrane (a proposed mechanism of action for pyrazinamide), 
nucleic acid synthesis (rifampin, quinolones) and cell wall synthesis (isoniazid, ethambutol, 
ethionamide and cycloserine) (Ma et al., 2007).  
Isoniazid (INH) is the most widely used treatment for TB and its latent infections (Heym et 
al., 1999). This drug enters the cell as a pro-drug, which is activated by Mycobacterium 
tuberculosis catalase-peroxidase enzyme (KatG). This enzyme activates INH and facilitates 
its interaction with various toxic reactive species (oxides, hydroxyl radicals and organic 
moieties) in the bacterial cell (Barry et al., 1998). Thus, weaken the components of the cell 
wall and finally, causing the death of the bacteria. INH targets inhA enzyme (enoylacyl 
carrier protein reductase), which is involved in the elongation of fatty acids in mycolic acid 
synthesis (Zhang and Telenti, 2000). The replacement of an amino acid in the NADH binding 
site of inhA results into INH resistance, preventing the inhibition of mycolic acid biosynthesis 
(Telenti et al., 1993). INH-resistant strains often lose catalase and peroxidase activities due to 
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KatG Ser315Thr mutation (Hazbon et al., 2006). Resistance to INH can also occur through 
mutations in the promoter region of inhA. This leads to over expression of inhA, or by 
mutations at the inhA active site, thereby lowering inhA affinity for INH (Rozwarski et al., 
1998).  
Rifampicin (RIF) has been used as a first-line drug in combination with other therapies for 
the treatment of TB infections. RIF is believed to inhibit bacterial DNA-dependent RNA 
polymerase (Shehzad et al., 2013). This drug interferes with RNA synthesis by binding to the 
β subunit of mycobacterial RNA polymerase, which is encoded by rpoB, thereby killing the 
organism. Resistance to RIF arises due to missense mutations in the gene. M. tuberculosis 
resistance to RIF occurs at a frequency of 10−7 to 10−8 as a result of mutations in rpoB (Dye 
and Williams, 2010). About 96% of all mutations are found in the 81-bp core region of the 
gene between codons 507 and 533, with the most common changes occurring in codons 
Ser531Leu, His526Tyr and Asp516Val (Zhang et al., 2003). 
Pyrazinamide (PZA) is another vital first-line drug used for the treatment of tuberculosis. It 
played an important role in reducing the duration of TB treatment (Salfinger et al., 1990). 
PZA is a pro-drug that requires conversion to its active form, pyrazinoic acid (POA) by the 
mycobacterial enzyme pyrazinamidase/nicotinamidase. The efflux system of the 
mycobacterial cell enables massive accumulation of POA in the bacterial cytoplasm, leading 
to disruption of the bacterial membrane potential (Zhang et al., 1999; Sheen et al., 2009). The 
exact mechanism of PZA resistance remains unknown. However, PZA resistance has been 
associated with defective pyrazinamidase/nicotinamidase activity which results from 
mutations that might occur at different regions (3-17, 61-85 and 132-142) of 
pyrazinamidase/nicotinamidase (Scorpio and Zhang, 1996). 
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Ethambutol (EMB) is a first-line drug used in combination with INH, RIF and PZA 
preventing the emergence of drug resistance mycobacterium. This drug interferes with the 
cell wall of M. tuberculosis through a synthetic mechanism thereby inhibiting arabinosyl-
transferase (embB), an enzyme involved in cell wall biosynthesis (Telenti et al., 1997). The 
enzyme has been proposed as the target of EMB in M. tuberculosis (Zhang and Yew, 2009). 
Mutation is the cause of ethambutol resistance and it occurs at a rate of approximately 1 in 
107 organisms. It increases the production of arabinosyl-transferase, which overwhelms the 
inhibitory effects of ethambutol. Studies have revealed five mutations in codon 306 
accounting for 70–90% of all ethambutol resistant strains (Van Niekerk and Ginsberg, 2009).  
Thus, the resistance of M. tuberculosis to TB-drugs is mostly due to mutation and this is a 
cause for concern. Therefore, it is important to search for new anti-tuberculosis agents, 
preferably those that can be readily and simply produced from medicinal plants.  
 
Figure 1.2: Schematic illustration of the sites of action for the available anti-tuberculosis 
drugs (Ma et al., 2007). 
8 
 
Due to the toxicity of tuberculosis medicines, they could cause serious adverse effects in the 
patients (Table 1.1). 
Table 1.1: Adverse effects associated with anti-tubercular drugs 
TB therapy Adverse effects 
Isoniazid Hepatitis, skin rash 
Rifampicin Abdominal pain, nausea, vomiting, hepatitis, thrombocytopenia purpura 
Cycloserine Convulsions, dizziness, headache, depression, psychotic reactions 
Pyrazinamide Arthralgia, hepatitis 
Streptomycin Vestibular and auditory nerve damage, renal damage 
Thioacetazone Skin rash, exfoliative dermatitis 
Kanamycin Vertigo, auditory nerve damage, nephrotoxicity 
Ethionamide Diarrhoea, abdominal pain, hepatotoxicity 
Ethambutol Eye problems, retrobulbar neuritis 
Paraaminosalicylic 
acid 
Anorexia, nausea, vomiting, hypersensitivity reactions 
 
Source: Mehta et al., 2015. 
 
 
1.1.3 Challenges in the treatment of tuberculosis 
Mycobacterium tuberculosis adopts diverse strategies to survive in the host lesions. These 
survival mechanisms make the pathogen resistant to the available TB-drugs, thus, the 
difficulty experienced in controlling the spread of this disease (Shehzad et al., 2013). The 
global epidemic of tuberculosis is further exacerbated by the existence of multi-drug 
resistant-TB (MDR-TB), extremely drug resistant-TB (XDR-TB) and totally drug resistant-
TB (TDR) which are successively more difficult to treat. MDR-TB is the resistance of TB to 
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isoniazid and rifampicin, the two most powerful first-line anti-TB drugs. XDR-TB is resistant 
to MDR-TB drugs, all fluoroquinolones and at least one of the second-line anti-TB injectable 
drugs including amikacin, kanamycin and/or capreomycin (Zhang and Yew, 2009; Nguta et 
al., 2015). The emergence of drug resistance in a patient could occur as a result of low 
adherence to treatment, inadequacy of the drug regimen (such as, wrong antibiotic choices or 
dosages, poor drug quality) and patient-dependent pharmacodynamic and pharmacokinetic 
properties of the drugs administered (Pasipanodya and Gumbo, 2011). 
The annual global burden of MDR-TB was estimated to 480,000 cases, 170,000 deaths, with 
about 9% of them being affected by XDR-TB (WHO, 2016). Treatment of MDR-TB required 
the use of the second-line drug up to 2 years. This process is costly and could produce severe 
adverse drug reactions in patients, thus only a few of the patients who entered into treatment 
successfully completed the treatment. Treatment failure could as well occur in some of these 
patients due to weaknesses in current regimens, national programmes, and operational 
challenges (Wallis, 2016). About 424,000 MDR TB cases are reported yearly in which 9.6% 
of MDR TB cases had XDR TB (WHO, 2009a; WHO, 2016). In many developing countries, 
the chances of recovery of patients with XDR-TB are extremely low and the spread of this 
strain raises the possibility of the return to a pre-antibiotic era (Raviglione, 2006; Mohajan, 
2015). This type of TB is of great concern among the people infected with HIV infection. 
Several cases of XDR-TB have been detected in at least 55 countries (Mohajan, 2015) around 
the world of which South Africa is included. The WHO estimated that 40,000 cases of XDR-
TB occur each year (WHO, 2009a). Due to the complexity of this TB, the patients need to be 
put on longer MDR-TB regimens to which one of the new drugs (bedquiline and delamanid) 
may be added (WHO, 2016). Another hurdle faced in the treatment of tuberculosis is the high 
prevalence of co-infection with Mycobacterium tuberculosis and HIV. These two infections 
are synergistic. About half of the people living with HIV/AIDS develop active TB (Corbett et 
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al., 2003). This disease is the leading killer of HIV positive people, with about 35% deaths in 
2015 (WHO, 2016). The annual tuberculosis report of the WHO states that “without new 
tuberculosis drugs and regimens, it will be very difficult to improve treatment outcomes in 
the near future” (Anderson et al., 2015).  
 
1.1.4 Herbal medicines  
Medicinal plants have continued to play an important role in the development of potent 
therapeutic agents due to their numerous chemical diversities (Gautam et al., 2007). Many 
conventional drugs such as quinine from cinchona tree, aspirin from willow tree, codeine and 
morphine from Papaver somniferum originated from plant. Others include digoxin from 
foxglove, atropine, ephedrine, reserpine and artemisinin derivatives from Artemisia annua 
(Chin et al., 2006; Kurokawa et al., 2010). According to WHO, about 70-80% of the 
developing countries still rely on herbal medicines for their primary health care; however this 
varies from countries to countries (WHO, 2002a). This is because of the general belief that 
herbal medicines are without any side effects, readily accessible and cost effective as well as 
their cultural acceptability and better compatibility with the human body (Gupta and Raina, 
1998; Pal and Shukla, 2003; Gratus et al., 2009; Hasan et al., 2009). Thus, the use of herbal 
remedies exceeds that of the conventional drugs by two to three times (WHO, 1998; Pal and 
Shukla, 2003).   
In the developed countries, such as the United States, about 38% of adults and 12% of 
children make use of complementary and alternative medicine (CAM) (NCCIH, 2016). In 
Europe, North America and other industrialized regions, over 50% of the population have 
used CAM at least once. About 75% of people living with HIV/AIDS use traditional 
medicine (TM)/CAM in San Francisco and London; 40% of the population in Hong Kong 
(WHO, 2002b; Chan, 2003) and 70% of all medical doctors in France and German regularly 
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prescribe herbal medicine (Murray and Pizzorno, 2000). All these people used CAM for the 
treatment of illnessess such as cardiovascular diseases, diabetes, hypertension and depression. 
The use of traditional medicine is not limited to developed countries; many people in 
developing countries still rely on herbal medicines for their primary care (Wachtel-Galor and 
Benzie, 2011). In Asia and Latin America, the populations continue to use herbal medicine as 
a result of historical circumstances and cultural beliefs. In China, TM accounts for around 
40% of all health care delivered and more than 90% of general hospitals in China have units 
for traditional medicine. Up to 70% of Indian and 80-90% of the population in Africa depend 
on traditional medicine to help meet their health care needs (WHO, 2009b). In Ghana, Mali, 
Nigeria and Zambia, the first line of treatment for 60% of children with high fever resulting 
from malaria is the use of herbal medicines (Peltzer, 2009). In South Africa, it was estimated 
that about three million people use indigenous medicines for their primary health care 
purposes, and exploration in the treatment of various ailments (Louw et al., 2002; Buwa and 
Afolayan, 2009). In the Eastern Cape Province, about 30 plants belonging to 21 families are 
used by the traditional healers for the treatment of TB and associated diseases (Lawal et al., 
2014). 
 
1.1.5 Need for the discovery of new drugs from herbal origin 
The emergence of drug resistant strains of Mycobacterium tuberculosis has complicated the 
treatment of TB. Due to the presence of “cross resistance” no single drug or combined 
therapy is able to control TB completly. This type of resistance is developed only against 
purified chemical compounds. Any single purified chemical compound has the ability to 
produce resistance in pathogens. Mycobacteria possess the capability to digest purified drugs 
by modifying their receptor structure according to the drugs, thus, slowly adapt and develop 
resistance against the anti-tubercular agents. However, pathogens do not induce the problem 
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of drug resistance to herbal medicines (Khadar, 2013; Mehta et al., 2015). Natural products 
and/or their semi-synthetic derivatives are therefore, important sources of new chemical 
compounds that might play an important role in the chemotherapy of tuberculosis (Pavan et 
al., 2009; Nguta et al., 2015b).  
 
1.1.6 Polyherbal medicines  
Polyherbal medicines are mixtures of various herbs which contain multiple active 
constituents and act synergistically against infections (Bhope et al., 2011). They have been 
used extensively for the treatment of various diseases for many centuries due to their 
medicinal and therapeutic application (Aslam et al., 2016). Several studies on the use of 
polyherbal medicines have revealed that these therapies possess pharmacological functions. 
For instance, Rajanyamalakadi, a polyherbal preparation which contains three herbal 
ingredients has been proven to show significant antidiabetic, hypolipidemic and antioxidant 
properties (Faizal et al., 2009). Also, Polyherbal Health Tonic Tea used for the treatment of 
an array of diseases affecting humans and Sanjivani Vati used for the treatment of cough and 
cold have been shown to possess significant pharmacological activities (Adeneye and 
Benebo, 2009; Gulati et al., 2010). Other Polyherbal remedies such as Livina, Rhumapar 
tablet, Diakyur and Sugar Remedy have been proven to contain pharmacological activities 
(Gairola et al., 2011; Patil et al., 2013; Singhal et al., 2014). These herbal remedies act on 
multiple targets at the same time to express high effectiveness in a vast number of diseases 
(Parasuraman et al., 2014). 
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1.2 Rationale and justification for this study  
The utility of the current drug regimens combination for tuberculosis have been limited due 
to incompliance issues of patients, which has resulted into the rise of strains that are resistant 
to some or the entire first and second-line antibiotics (Hundeiker, 2010). Due to the resistance 
of Mycobacterium tuberculosis to commonly prescribed antimicrobials, relatively high cost 
and limited access to synthetically derived drugs, communities most especially in Africa have 
relied on the use of herbal medicine for the treatment of their ailment (WHO, 2003; Orodho 
et al., 2011). In the continuing search for effective treatment, polyherbal remedies are used as 
alternative medicines in the Eastern Cape Province of South Africa. It is important to 
document the ingredients used in the formulations, as the information would be very 
important in the development of serious armament for the treatment of tuberculosis.  
Also, with the ever increasing use of polyherbal medicines and their global market expansion, 
safety has become a major concern for both health authorities and the public in many 
countries (WHO, 2007). Several investigations have shown that these remedies are associated 
with a broad variety of residues and contaminants such as microbial agents and heavy metals 
(Candlish et al., 2001; Govender, et al., 2006; Alwakeel, 2008; Abba et al., 2009; Kaume et 
al., 2012; Ting et al., 2013; Noor et al., 2014). Evaluation of the microbial contamination of 
these remedies is neccessary to justify their folkloric usage. There is equally a need to 
conduct toxicological evaluation on these herbal formulations in order to acquire their 
maximum benefits and safety, even though they might have been proven to be efficacious in 
pharmacological studies or by clinical evaluation (Tatke et al., 2012).  
With the increasing incidence of drug-resistant strains of tuberculosis each year in South 
Africa (Hughes and Osman, 2014), coupled with the suppression of human defence 
mechanism during the course of active tuberculosis, many patients become vulnerable to 
pathogenic and opportunistic pathogens; and, as such, acquires fungal infection in addition to 
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bacterial, viral and parasitic infections (Sunita and Mahendra, 2008; Querido et al., 2011). 
Scientific validation of the herbal medicines against M. tuberculosis and other associated 
pathogen is thus necessary in proving their effectiveness. Also, in order to authenticate the 
polyherbal remedies used for the treatment of tuberculosis in the Eastern Cape Province, 
evaluation of the microbial containants, toxicity, antimicrobial and mineral analyses were 
carried out to validate their use and guarantee the safety of the users. This reasearch will not 
only promote the use of traditional medicines in South Africa but also in other countries. 
 
1.3 Objectives of the study 
The overall objective of this study was to document the polyherbal medicines that are used 
for the treatment of tuberculosis, identify the bacteria and fungi present, determine the 
toxicity, nutritive properties and antimicrobial activity of the polyherbal medicines in the 
Eastern Cape Province, South Africa. 
The specific objectives are: 
1. To carry out an ethno-medicinal survey of polyherbal medicines used for the 
treatment of tuberculosis in the Eastern Cape, South Africa. Such documentation 
includes the names of the plants including the non-herbal inclusions, part used, 
method of preparation and the dosage of polyherbal formulations used for the 
treatment of tuberculosis. 
2. To identify the different bacterial contaminants present in the herbal medicines using 
rapid 16S rRNA technique. 
3. To identify the different fungal populations in the polyherbal medicines. 
4. To determine the toxicity potential of the herbal remedies using brine shrimp test. 
5. To determine the anti-Mycobacterium tuberculosis activity of the polyherbal 
medicines. 
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6. To determine the effect of the remedies on opportunistic bacterial and fungal 
pathogens of humans infected with tuberculosis. 
7. To evaluate some important vitamins and mineral nutrients present in the polyherbal 
medicines. 
 
1.4 Description of the study area 
This study was carried out in five communities within the Amathole District Municipality of 
the Eastern Cape Province, South Africa (Figure 1.2). The area falls within latitudes 30°00′ to 
34°15′S and longitudes 22°45′ to 30°15′E. It is bounded by the sea on the East and the drier 
Karroo (semi-desert vegetation) in the West. The elevation ranges from sea level to 
approximately 2,200 m in the North of the province. The Amathole District Municipality lies 
at the heart of the Eastern Cape Province. The District stretches from the Indian Ocean 
coastline in the South to the Amathole Mountains in the North, and from Mbolompo Point 
(south of the Hole-in-the-Wall along the Transkei Wild Coast) in the East to the Great Fish 
River in the West. Presently, about 1.7 million people living in the study area (Afolayan 
2003) is made up of Africans (91%), coloureds (3%) and whites (6%). The main tribes of the 
area are Xhosa-speaking people who are divided into several tribes with related but distinct 
heritages (Dyubeni and Buwa, 2012). 
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Figure 1.3: Map of Amathole District Municipality (Famewo et al., 2016) 
 
1.5 The structure of the thesis 
This thesis is composed of discrete chapters that have been published, accepted or under 
review in various peer-reviewed accredited journals. The introduction and literature review 
are presented in Chapter 1. The ethno-medicinal survey of polyherbal medicines used for the 
treatment of tuberculosis in Amatole District Municipalities of the Eastern Cape Province of 
South Africa is presented in Chapter 2. The different bacterial contaminants identified in the 
remedies are reported in Chapter 3 while Chapter 4 is composed of the report of the fungal 
contaminants present in the polyherbal medicines. The anti-Mycobacterium tuberculosis 
activity of the nine remedies is reported in Chapter 5 while Chapter 6 deals with the effect of 
the remedies on opportunistic bacterial and fungal pathogens of humans infected with 
tuberculosis. In Chapter 7, the toxicity potential of the herbal remedies using brine shrimp 
test was reported. Chapter 8 accounts for the vitamins and mineral nutrients composition 
present in the polyherbal medicines. The general discussion, conclusions and 
recommendations emanating from this study are presented in Chapter 9.  
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Ethno-medicinal documentation of polyherbal medicines used for the treatment
of tuberculosis in Amathole District Municipality of the Eastern Cape Province,
South Africa
Elizabeth Bosede Famewo, Anna Maria Clarke and Anthony Jide Afolayan
Faculty of Science and Agriculture, University of Fort Hare, Alice, South Africa
ABSTRACT
Context: Tuberculosis (TB) has remained a devastating global public health problem. In the continuing
search for effective treatment, polyherbal remedies used as alternative medicines in the Eastern Cape
Province of South Africa were surveyed.
Objective: The survey collected information and documents the list of ingredients such as the name of
the plants used including the non-herbal inclusions, type and dosage of polyherbal formulations used for
the treatment of TB.
Materials and methods: The survey was conducted over a period of 6 months using semi-structured
questionnaires amidst informal conversations with the traditional healers in five communities in the study
area. The chosen study area is the third infected Province with TB in South Africa.
Results: A total of nine polyherbal preparations were collected. Information on the parts of the plant
used, mode of preparation and the dosage used were documented. In total, the herbs belong to 20 fami-
lies of which Apiaceae, Liliaceae, Strychnaceae, Rutaceae and Hypoxidaceae are the most prominent.
However, members of Apiaceae were commonly mentioned for the preparation of the remedies. The two
most frequently used plants were Allium sativum L. (Liliaceae) and Strychnos decussata (Pappe) Gilg.
(Strychnaceae). Rhizome was the commonest parts used, followed by the roots and barks.
Conclusions: This paper provides significant ethno-medicinal information on polyherbal medicines used
for the treatment of TB in the study area. The therapeutic claims made on medicinal plants used for the
preparations are well supported by the literature, with many of the species having antimicrobial
properties.
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Introduction
Tuberculosis (TB) caused by Mycobacterium tuberculosis has
remained one of the most prevalent causes of mortality in devel-
oping nations, especially in the Asian and African continents.
The disease remains a big problem in these countries probably
due to inadequate means for the management and treatment of
the disease. According to World Health Organization (2002),
about 95% of the approximately eight million cases of TB occur
each year in Africa having the highest incidence. However, South
Africa is the third highest incidence country after India and
China with about 80% of the population infected with the dis-
ease. This rate has increased by 400% over the past 15 years
most especially among the people living with human immuno-
deficiency virus (HIV) (Lall & Meyer 1999; Green et al. 2010).
The conventional medical treatment for TB consists of a regi-
men of antibiotics taken over the course of several months. For
this reason, many people especially those living in the rural com-
munities do not strictly adhere to the plan for effective treat-
ment; thus making the disease difficult to treat with conventional
medicines (Lange et al. 2014). In addition, the side effects such
as gastrointestinal upset, hepatitis, drug interactions and hearing
loss associated with the consumption of these drugs have dis-
couraged many people from continual use of the orthodox
medicines (Laxminarayan et al. 2006). Also, the emergence of
multi-drug resistant tuberculosis (MDRTB: resistant to the two
most effective first-line drugs, isoniazid, and rifampin), exten-
sively drug-resistant tuberculosis (XDRTB: MDRTB with add-
itional resistance to at least one fluoroquinolone and one
injectable drug) and totally drug-resistant (TDR) tuberculosis
have made TB exacerbated, thus becoming a global health prob-
lem. The continual resistance of M. tuberculosis to commonly
prescribed antimicrobials has made people fall back on herbal
medicines for various therapeutic purposes (Orodho et al. 2011).
The inhabitants of the Eastern Cape Province have a long his-
tory of traditional plant usage for the treatment of various dis-
eases including TB (Grierson & Afolayan 1999). In fact, about 30
plants belonging to 21 families are used by the traditional healers
for the treatment of TB and associated diseases (Lawal et al.
2014). These plants are commonly combined with polyherbal
remedies, which are prescribed in different formulations.
However, the lists of ingredients used for the polyherbal formula-
tions in the study area are yet to be documented. This informa-
tion is very important in the development of serious armament
for the treatment of TB, since a greater number of TB patients
depend on traditional herbalists for their medical needs.
Therefore, the aim of this study is to collect information and
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document the list, type, dosage and nature of the polyherbal 
medicines used for the treatment of TB in this Province, and to 
collect the information on the ingredients of the polyherbal for-
mulations such as the name of the plants used including the 
non-herbal inclusions present in each remedy.
Materials and methods
Study area
The present study was carried out in five communities within the 
Amathole District Municipality of the Eastern Cape Province, South 
Africa (Figure 2.1). The area falls within latitudes 30000 to 34150S 
and longitudes 22450 to 30150E. It is bounded by the sea on the east 
and the drier Karroo (semi-desert vegetation) in the west. The 
elevation ranges from sea level to approximately 2200 m in the 
north of the province. The Amathole District Municipality lies at 
the heart of the Eastern Cape Province. The District stretches from 
the Indian Ocean coastline in the south to the Amathole Mountains 
in the north, and from Mbolompo Point (south of the Hole-in-the-
Wall along the Transkei Wild Coast) in the east to the Great Fish 
River in the west. Presently, about 1.7 million people live in the 
study area (Afolayan 2003) including Africans (91%), coloreds (3%) 
and whites (6%). The main tribes of the area are Xhosa-speaking 
people(s) who are divided into several tribes with related but 
distinct heritages (Dyubeni & Buwa 2012).
Data collection
The survey on the polyherbal medicines was conducted between 
March and August 2015 through semi-structured questionnaires 
amidst informal conversations with the traditional healers who 
use medicinal plants for the treatment of TB (Ajibesin et al. 
2012; Asiimwe et al. 2013). The survey was carried out among 
the herb healers because they inherited the knowledge from their 
forefathers, therefore, passing it from one generation to another
generation. The interviews were conducted in Xhosa, the local 
language of the informants, and English. The remedies were 
already prepared with water by the herbal healers into clean 2 L 
containers. They were purchased and the following information 
was collected for proper documentation; the local name of the 
herbs used for the polyherbal formulations, plant parts used, 
methods of preparation, modes of administration of the herbal 
remedy, doses and duration of treatment.
Results and discussion
This study revealed that polyherbal remedies play an important 
role in healthcare delivery in South Africa, especially among the 
people living in the rural settings of the Eastern Cape Province. 
The application of these remedies in the management or treat-
ment of diseases covers a wide range of conditions from chronic 
conditions, psychosocial problems, acute conditions, generalized 
pain, TB and HIV infection and acquired immune deficiency 
syndrome (AIDS). Ethnobotanical surveys have extensively 
studied South African populations of adults and children with 
several illnesses (Bodkin 2003).
A total of nine polyherbal medicines used for the treatment of TB 
were recorded and collected from the study area (Table 2.1); these 
are from East London (EL), King Williams Town (KWT) and 
Fort Beaufort (FB). Others are from Alice (AL) and 
Hogsback (HB). Each remedy was labelled and coded according 
to the place of collection; namely King Williams Town site A 
(KWTa), King Williams Town site B (KWTb), King Williams 
Town site C (KWTc), Hogsback first site (HBfs), Hogsback 
second site (HBss), Hogsback third site (HBts), East London 
(EL), Alice (AL) and Fort Beaufort (FB). The small number of 
remedies obtained in this study was because only a few trad-
itional healers treat TB. They claim to have acquired the know-
ledge from their ancestors, and this knowledge has been 
transferred from one generation to another. The herbal healers in 
the Province diagnosed TB based on patients’ signs and
Figure 2.1. Map of Amathole District Municipality. (Source: Famewo et al. 2016)
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symptoms before commencing with the treatment. Patients are 
carefully observed and symptoms such as blood in the sputum, 
prolonged coughing, chest pain and breath shortness including 
weight loss are taken as confirmation of TB.
The polyherbal remedies in the study area were prepared 
from 24 plants. The six most commonly mentioned plant families 
used in the preparation of the polyherbal formulations in terms 
of number and percentage are Apiaceae [5(25%)], followed by 
Liliaceae [4(20%)], Strychnaceae [4(20%)], Rutaceae [4(20%)], 
Solanaceae [2(10%)] and Primulaceae [2(10%)] (Figure 2.2). 
Members of Apiaceae have been previously cited as the most 
commonly used in this Province not only for the treatment of 
TB but also as an antidote for influenza, hypertension and to 
expel intestinal worms (Bisi-Johnson et al. 2010). The therapeutic 
claims made on most of the medicinal plants used for the
preparation of these remedies are well supported by the litera-
ture, with many of the species having antimicrobial properties 
(Buwa & Afolayan 2009; Green et al. 2010).
The most frequently used plant parts in this study was rhi-
zomes [10(27%)], followed by bark [8(22%)], and roots 
[8(22%)]. Others are leaves [6(16%)], corms (3(8%)] and vege-
table [2(5%)] as shown in Table 2.1. The four most frequently 
used plants are Allium sativum L. (Liliaceae) [4(17%)], 
Strychnos decussata (Pappe) Gilg. (Strychnaceae) [4(17%)], 
Daucus carota L. (Apiaceae) [3(13%)] and Hypoxis argentea 
(Fiscand) (Hypoxidaceae) [3(13%)]. Other plants such as 
Agathosma betulina (Berg) (Rutaceae) [2(8%)], Capsicum ann-
uum L. (Solanaceae) [2(8%)] and Rapanea melanophloeos 
L. (Primulaceae) [2(8%)] are used for a few polyherbal prepara-
tions in the Province as represented in Figure 2.3.
Table 2.1. Polyherbal medicines used for the treatment of TB in Amathole District Municipality, Eastern Cape Province, South Africa.
Name code Ingredients Botanical name Family Parts used
Methods of preparation, administra-
tion and dosage
AL Mountain garlic A. sativum (L.) Liliaceae Rhizome Infusion; Take 100mL of the herbal
mixture orally twice in a day for a
period of 5–8 weeks.
Mlomo mnandi Glycyrrhiza glabra (L.) Fabaceae Root
Red carrot Daucus carota (L.) Apiaceae Root
Inongwe Hypoxis argentea (Fiscand) Hypoxidaceae corms
Mnonono S. decussate (Pappe) Gilg Strychnaceae Bark
River pumpkin Gunnera perpensa (L.) Gunneraceae Rhizome
Herbal menthol leaf Mentha piperita (L.) Lamiaceae Leaf
Herbal buchu water Agathosma betulina (Berg) Rutaceae Leaf
EL Inongwe Hypoxis argentea (Fiscand) Hypoxidaceae corms Infusion; Take 100mL of the remedy
orally thrice in a day for a period
of 5–8 weeks.
Intelezi Haworthia reinwardtii (Haw) Xanthorrhoeaceae Leaf
Ngcambumvuthuza Ranunculus multifidus (Forssk) Ranunculaceae Root
Inqwebeba Albuca flaccid (Jacq.) Asparagaceae Leaf
Iqwili Alepidea amatymbica (Eckl. &
Zeyh.)
Apiaceae Rhizome
FB Buchu leaf Agathosma betulina (Berg) Rutaceae Leaf Decoction; Take 75mL of the remedy
orally thrice in a day for a period
of 5–8 weeks.
Mountain garlic A. sativum (L.) Liliaceae Rhizome
Ginger Zingiber officinalis (L.) Zingerberaceae Rhizome
Chilli pepper Capsicum annuum (L.) Solanaceae Vegetable
KWTa Maphipha Rapanea melanophloeos (L.) Primulaceae Bark Infusion; Take half a cup thrice in a
day for a period of 5–8 weeks.Mnonono S. decussate (Pappe) Gilg Strychnaceae Bark
Ixonya Kniphofia drepanophylla
(Baker)
Asphodelaceae Root
Inongwe Hypoxis argentea (Fiscand) Hypoxidaceae Corms
Sicimamlilo Pentanisia prunelloides
(Klotzsch)
Rubiaceae Rhizome
Iphuzi Centella eriantha (Rich.) Apiaceae Rhizome
KWTb Umdlavuza Lauridiatetragonia (L.F.) Celastaceae Root Infusion; Take 100mL of the polyher-
bal remedy orally thrice in a day
for a period of 5–8 weeks
Mnonono S. decussate (Pappe) Gilg Strychnaceae Bark
Inceba emhlophe Hermannia sp. (L.) Malvaceae Root
KWTc Mnonono S. decussate (Pappe) Gilg Strychnaceae Bark A little quantity of the herb must be
chewed immediately after the pol-
yherbal remedy in KWT B has
been administered, thrice in a day
for a period of 5–8 weeks.
HBfs Red carrot Daucus carota (L.) Apiaceae Root Infusion; Take 75mL of the polyher-
bal remedy orally thrice in a day
for a period of 3–5 weeks
Mlungu mabele Zanthoxylum capense (Thunb.) Rutaceae Bark
Calmoes Acorus calamus (L.) Acoraceae Rhizome
Mountain garlic A. sativum (L.) Liliaceae Rhizome
HBss Buchu leaf Agathosma betulina (Berg) Rutaceae Leaf Decoction; Take 75mL of the herbal
mixture orally thrice in a day for a
period of 3–5 weeks
Chilli pepper Capsicum annuum (L.) Solanaceae Vegetable
HBts Maphipha Rapanea melanophloeos (L.)
Mez
Primulaceae Bark Infusion; Take 75mL of the herbal
mixture orally thrice in a day for a
period of 3–5 weeksRed carrot Daucus carota (L.) Apiaceae Root crop
Uroselina Cinnamomum camphora (L.) J.
Presl
Lauraceae Bark
Mountain garlic A. sativum (L.) Liliaceae Rhizome
AL: Alice; EL: East London; FB: Fort Beaufort; KWTa: King Williams Town site A; KWTb: King Williams Town site B; KWTc: King Williams Town site C; HBfs: Hogsback
first site; HBss: Hogsback second site; HBts: Hogsback third site.
The importance of Fabaceae lies in their effectiveness in the treatment of a wide variety of human ailments such as allergy, cough, hiccups, stomach ulcers, viral
fevers, wounds and swellings (Padal et al. 2013). They also possess high level of biological activity due to the variety of chemically active constituents such as tan-
nins, flavonoids, alkaloids, and terpenes present in members of this family (Molares & Ladio 2011).
Zingiberaceae is rich in substances having therapeutic value such as terpenoids, tannins and flavonoids. The rhizomes of this family are aromatic, tonic and stimu-
lant. They are used as antimicrobial, antiarthritic, antioxidant, anticancer, antiinflammatory, antidiabetic, neuroprotective and larvicidal agents (Victorio 2011).
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The polyherbal medicines were prepared mainly by infusion 
[6(67%)] and decoction [2(22%)] with the exception of S. decus-
sate, which should be chewed immediately after KWTb remedy 
has been administered (Table 2.1). This is an indication that 
the Eastern Cape traditional herbal healers use water mainly for 
the preparation of anti-TB treatments. These methods of 
extraction have been adopted from the ancient time. They 
seem to yield active principles required to treat TB (Nguta et 
al. 2015). The internal method of administration, which is by 
oral, was the main method of administrating all the remedies.
The diverse uses of each plant can be explicated by the fact 
that, a single plant can serve many medicinal purposes or perform 
different functions (Lawal et al. 2010). However, the combination 
of these herbs in polyherbal medicines probably results in better 
therapeutic activities and reduces the toxicity of such remedies. 
Naturally, polyherbal remedies contain multiple active constitu-
ents, which act synergistically against infections (Bhope et al. 
2011). A similar study by Amodu et al. (2013) revealed that poly-
herbal medicines were effective against Mycobacterium tubercu-
losis. Probably, these therapies have gained popularity in both
developed and developing countries because of their natural origin
and fewer side effects for the treatment of various chronic and
acute ailments (Ahmad et al. 2006; Benzie & Wachtel-Galor 2011).
Polyherbal medicines are current pharmacological principle hav-
ing the advantage of producing maximum therapeutic efficacy
with minimum side effects to the consumers (Ebong et al. 2008).
The cross-cultural acceptance and use of polyherbal remedies in
different geographical zones is an indication of the potential of
polyherbal as future sources of new classes of drugs against TB.
Conclusions
This paper provides significant ethno-medicinal information on
polyherbal medicines used for the treatment of TB in Amathole
District Municipality of Eastern Cape Province. Africa is endowed
with a biodiversity of medicinal plants, many of which are cur-
rently used in the traditional management of TB. The study shows
that people in the study area still depend on polyherbal medicines
for the treatment and management of TB. The documented rem-
edies reflect rich ethno-medicinal knowledge in the province.
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Figure 2.2. Frequency of the most used plant families in the preparation of polyherbal medicines for the treatment of TB in the study area.
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Figure 2.3. Occurrence of plant species used for the preparation of polyherbal medicines for the treatment of TB in the study area.
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However, further test are required to validate the ethno-medicinal
usage of these polyherbal remedies as anti-TB agents.
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Identification of bacterial contaminants
in polyherbal medicines used for the
treatment of tuberculosis in Amatole
District of the Eastern Cape Province, South
Africa, using rapid 16S rRNA technique
Elizabeth Bosede Famewo, Anna Maria Clarke and Anthony Jide Afolayan*
Abstract
Background: Polyherbal medicines are used for the treatment of many diseases in many African and Asian
communities. With the increasing use of these remedies, several investigations have shown that they are associated
with a broad variety of residues and contaminants. This study investigates the presence of bacteria in the polyherbal
medicines used for the treatment of tuberculosis (TB) in the Eastern Cape Province of South Africa.
Methods: Bacterial DNA was extracted from the polyherbal medicines, and a fragment of the bacterial 16S
rRNA gene was amplified by PCR with universal primers 27F and 518R. The amplicons were visualised on
agarose gel electrophoresis, followed by end repair and adaptor ligation. They were further purified and
quantified using Library Preparation kit NEBNext® UltraT DNA Library Prep Kit for Illumina, and the amplicons
were run on illumina’s MiSeq platform.
Results: Different bacterial species were identified in all each of the polyherbal medicines. Generally, the most
prominent and common bacteria recovered from all the samples were Bacillus sp., Enterobacter sp., Klebsiella
sp., Rahnella sp., Paenibacillus sp., Clostridium sp. and Pantoea sp. Others are Pseudomonas sp., Raoultella ornithinolytica,
Salmonella enterica and Eubacterium moniliforme.
Conclusions: This study, thus, revealed the presence of pathogenic and non-pathogenic bacteria in the polyherbal
medicines used for the treatment of tuberculosis in the study area. The implications of the findings are discussed in
relation to the health care of the patients of tuberculosis in the study area, having in mind that they are
immunocompromised individuals.
Keywords: Polyherbal medicines, Tuberculosis, Bacteria, Public health, Sequencing
Background
Polyherbal medicines have been used for various thera-
peutic purposes as far back as the origin of mankind. In
South Africa, it is estimated that three million people
currently use herbal remedies (polyherbal medicines) for
their health care purposes especially in the treatment of
diarrhoea, diabetes, stomach illnesses, wound infections
and tuberculosis [1–3].
About 1 % of the South Africa population is estimated
to develop tuberculosis yearly [4]. The country accounts
for one quarter of the global burden of HIV-associated
tuberculosis (TB) [5]. This is stimulated by the high
rates of latent tuberculosis infection and the increase in
the prevailing rates of infection [4]. In fact, about 50 %
of people among the age group 15 and 77–89 % of
adults have evidence of latent TB infection [6, 7]. The
use of the current drug regimen combinations for TB is
limited due to patients’ non-compliance, which has
resulted in the rise of strains that are resistant to some
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C (KWTc), Hogsback first site (HBfs), Hogsback second
site (HBss), Hogsback third site (HBts), East London (EL),
Alice (AL) and Fort Beaufort (FB). The small number of
remedies obtained in this study was due to the fact that
only a few traditional healers treat and sell the remedies
for TB. They claim to have acquired the knowledge from
their ancestors, and this knowledge is been transferred
from one generation to another. The samples were then
transported to Medicinal Plants and Economic Develop-
ment (MPED) Research Centre for analysis.
DNA extraction
The total bacterial DNA was extracted in a clean and
sterilized environment using ZR Fungal/Bacterial
MiniPrep™ Kit (Zymo Research, USA). The method of
[21] with slight modification was used for the extraction.
One millilitre of each sample was pipetted into sterile
eppendorff tubes and centrifuged at 12,500 rpm for
10 min. The supernatant was discarded, and the cell
pellets were collected. The protocol in the extraction kit
was followed.
PCR amplification of bacterial DNA
Polymerase chain reaction (PCR) was performed using
the extracted DNA from each of the samples. The bac-
terial 16S rRNAs were amplified using the oligonucleo-
tide primers 27F (5′-GGT AGA GTT TGA TCC TGG
CTC AG-3′) and 518R (5′-ATT ACC GCG GCT GCT
GG-3′). The 16S rRNA gene contains nine variable
regions (designated V1 to V9) of which we chose the
V1-V3 regions, which has previously proven useful in
research-oriented metagenomic surveys [22]. A total re-
action volume of 25 μL was used, which contained
12.5 μL Master Mix (Thermo Scientific, EU Lithuania),
1 μL each of 10 μM of both forward and reverse primer
solutions (Inqaba Biotech, SA), 5.5 μL of nuclease free
water and 5 μL template DNA. Reactions was performed
in the thermocycler (Bio-Rad Mycycler, USA) using
the following cycling conditions: initial denaturation
at 94 °C for 1 min, followed by 30 cycles of denaturation
at 94 °C for 1 min, annealing at 58 °C for 1 min, extension
at 72 °C for 1.5 min and final extension at 72 °C for
10 min [23]. In order to confirm the products size, 5 μL of
the amplicons was analysed by gel electrophoresis in 1 %
agarose (Merck, SA) stained with 3 μL ethidium bromide
(Sigma-Aldrich, USA). A 100 bp DNA ladder for 16S
rRNA (Thermo Scientific, (EU) Lithuania) was included
for band size estimation purposes. All gels were run in
0.5X TBE buffer at 95 V for 1 h and visualised by UV
trans-illumination (Alliance 4.7, France).
Purification of 16S rRNA gene amplicons and sequencing
The bacterial 16S rRNA gene amplicons were purified with
the Zymoclean™ Gel DNA Recovery kit (ZymoResearch
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or the entire first and second-line antibiotics [8]. The 
emergence of multi-drug resistant tuberculosis 
(MDRTB), extensively drug resistant tuberculosis 
(XDRTB), and to-tally drug resistant tuberculosis 
(TDR) has exacerbated the global health problem [9, 
10]. Due to the high resist-ance of M. tuberculosis to 
commonly prescribed antimi-crobials, relatively high 
cost and limited access to synthetically derived 
drugs, most communities especially in Africa still rely 
on the use of polyherbal medicine for the treatment of 
their ailments [11, 12]. Yet, these medi-cines have been 
reported to contain a number of microbial and heavy 
metal contaminants [13–16].
Medicinal herbs frequently harbour a large number of 
microbes originating from the soil, and these microor-
ganisms normally adhered to leaves, stems, flowers, 
seeds and roots of plants [17]. The contamination of 
herbal products with Enterobacteriaceae, Bacillus spp., 
Salmonella spp., Staphylococcus aureus, Penicillium spp. 
and Aspergillus spp. have been reported by [18]. Also, 
elevated levels of bacterial and fungal contaminants, 
such as Escherichia coli, yeast, Penicillium spp., Aspergil-
lus and Fusarium, were observed in herbs and spices by 
[14, 19, 20]. The presence of these contaminants in the 
herbal products might adversely affect the health status 
of the consumers due to their immunocompromised 
conditions. Microbial infections have posed a health 
problem throughout the world, thus, the safety of the 
consumers of herbal products is of utmost importance.
To the best of our knowledge, the microorganisms 
present in some of the polyherbal medicines used for 
the treatment of TB in Amathole District Municipality 
of the Eastern Cape Province have not been investi-
gated despite the mass consumption of the medicines. 
Most of these polyherbal remedies are prepared in the 
form of concoctions or infusions and are left at room 
temperature over a long period of time depending on 
how rapid the patients respond to treatment. During 
this period, the mineral elements present in these rem-
edies may facilitate the growth of microorganisms. 
Thus, this study therefore aimed at identifying different 
bacteria present in some of the polyherbal medicines 
used for treatment of TB in the study area using 
molecular based technique.
Methods
Sample collection
A total of nine polyherbal medicines used for the treat-
ment of TB were purchased from the traditional herbal 
sellers in five communities, namely East London (EL), 
King Williams Town (KWT), Hogsback (HB), Alice (AL) and 
Fort Beaufort (FB) as shown in Fig. 3.1. Each remedy  was 
labelled and coded according to the place of collection, 
viz: King Williams Town site A (KWTa), King 
Williams Town site B (KWTb), King Williams Town site
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Corporation, Irvine, USA) and quantified using NanoDrop 
Fluorospectrometer ND3300 fragment size (Agilent Bioa-
nalyzer 2100) prior sequencing. Followed by end repair 
and adaptor ligation and quantification of each library 
using Library Preparation kit (NEBNext® UltraT DNA 
Library Prep Kit for Illumina), before running them on 
illumina’s MiSeq platform following the amplicon sequen-
cing protocol [24].
Results
Bacterial families and species identified in the remedies 
The findings of this study revealed the presence of both 
pathogenic and non-pathogenic bacteria in the polyher-
bal medicines used for the treatment of tuberculosis in 
the Eastern Cape Province of South Africa. All the iden-
tified bacteria in the therapies belong to 12 families. 
Only one of the families could not be identified (Fig. 
3.2). However, the prevalent families in all the 
polyherbal medicines are the Enterobacteriaceae, 
Bacillaceae and Paenibacillaceae (Fig. 3.2).
While the majority of the bacteria identified in KWTa 
remedy are Enterobacteriaceae (68 %), others were Bacil-
laceae (23 %), with 9 % remaining unknown (Fig. 3.3a). In
the same vein, Enterobacteriaceae are the dominant 
organisms in KWTb remedy and only 8 % remaining un-
known (Fig. 3.3b). The family Bacillaceae dominate KWTc 
therapy (66 %), whereas only 3 % of the bacteria are 
unknown (Fig. 3.3c). The identities of the majority of bac-
teria present in the herbal medicines sourced from AL 
and EL were unknown (84 and 86 %, respectively), with 
the remaining bacteria belonging to 16 and 5 families in 
AL and EL samples, respectively (Figs. 3.3d, e). A high 
number of bacteria identified in FB belong to Paenibacil-
laceae (98 %) as against a few other remedies where their 
population is insignificant (Fig. 3.3f). Similarly, HBfs, HBss 
and HBts remedies were dominated by Enterobacteria-
ceae (Figs. 3.3g–i).
This study further investigated the bacterial species 
present in each of the polyherbal medicines. The overall 
blast output revealed that these  polyherbal remedies
are contaminated with different bacterial genera and 
species including Bacillus sp., Klebsiella sp., Rahnella 
sp., Paenibacillus sp., Enterobacter sp., Pantoea sp., 
Clostridium sp., and a few unknown (Table 3.1). Some of 
these bacteria that are clinically pathogenic to human 
include Raoultella ornithinolytica, Rahnella aquatilis,
Fig. 3.1 Map of Amathole District Municipality
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Bacillus anthracis, Bacillus cereus, Salmonella enteric,
Enterobacter cloacae, Klebsiella oxytoca and Klebsiella
pneumonia. Others such as Enterobacter asburiae,
Paenibacillus polymyxa, Pantoea rwandensis, Klebsiella
variicola and Pseudomonas sp. are opportunistic patho-
gens causing opportunistic infections in individuals
with impaired immunity.
Discussion
The use of polyherbal medicines for the treatment of
various diseases is still a significant practice in the devel-
oping countries including South Africa. With the popu-
larity and global market expansion, the safety of herbal
products has become a major concern to public health
[25]. In this study, all the polyherbal therapies used for
the treatment of tuberculosis are orally consumed in the
form of water-extracted remedies. Naturally, the ingredi-
ents used for the preparation of these remedies are not
usually sterilized before soaking in water, hence the pres-
ence of different bacteria species and families identified
in the polyherbal medicines. The main source of con-
tamination could be from the soil, water, plant or other
raw materials and the containers used. Since these
remedies are not prepared in a sterile manner, another
possible source of contamination could be contaminants
from the personnel(s), unhygienic production condi-
tions, during harvesting, drying and storage. In addition,
environmental factors such as temperature, humidity
and extent of rainfall during pre-harvesting and post-
harvesting periods can influence the microbial contam-
ination of these medicinal herbal [26].
The presence of Bacillaceae, such as B. cereus and B.
anthracis, and Enterobacteriaceae including R. ornithino-
lytica, Rahnella sp., Klebsiella sp. and Enterobacter sp.
in these polyherbal medicines is a cause for concern.
Some of these bacteria are pathogenic to humans while 
others are opportunistic pathogens (Table 3.1) but could 
be serious public health hazard causing opportunistic 
infection and reduces the immunity of the immune-
suppressed consumers. R. ornithinolytica (formerly named 
Klebsiella ornithinolytica) was identified in KWTa remedy. 
This bacterium is Gram-negative, non-motile, encapsu-
lated and aerobic bacillus [27]. Though an uncommon 
human pathogen, about 86 infectious cases of this organ-
ism have been reported [28]. This pathogen has been 
linked to bacteremia [29, 30], sepsis [31], acute suppur-
ation of the pancreatic duct [32], soft tissue infection 
[33], enteric fever [34], renal cysts [35] and urinary 
tract infection [36]. Also, it expresses chromosomal 
class A β-lactamases, which confer resistance to ampicillin 
and other aminopenicillins [28].
R. aquatilis was identified in AL remedy, KWTa, KWTb
and KWTc remedies (Table 3.1). The bacterium is a 
faculta-tively anaerobic, nitrogen-fixing and Gram-
negative rod-shaped organism. It has been reported to 
cause infections such as bacteremia, sepsis, respiratory 
infection, urinary tract infection and wound infections 
most especially in immune-suppressed individuals [37, 
38]. Also, about 18 cases of human infection caused by 
R. aquatilis has been reported, and majority of these
infections were accompan-ied by diabetes mellitus,
alcoholism, cancer and AIDS [38]. The presence of
this bacterium in the polyherbal remedies is a cause for
concern considering the immuno-compromised status of
the patients.
Bacillus species such as Bacillus cereus, B. anthracis 
and B. subtilis were also identified in the polyherbal 
remedies. Bacillus cereus is a Gram-positive, aerobic-to-
facultative, spore-forming rod bacterium bearing close 
phenotypic and genetic relationships to several Bacillus 
species most especially B. anthracis [39]. This bacterium
Fig. 3.2 Percentage occurrence of each bacteria family identified in all the polyherbal remedy
Famewo et al. Journal of Health, Population and Nutrition  (2016) 35:27 Page 4 of 9
40
a b
c d
e f
g h
i
Fig. 3.3 Relative frequencies of contaminating organisms in each polyherbal remedy
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Table 3.1 Pathogenic and non-pathogenic bacterial species identified metagenomically from the polyherbal medicines used for the treatment of tuberculosis in the Eastern 
Cape Province of South Africa
KWTa KWTb KWTc AL EL FB HBfs HBss HBts
*aRaoultella
ornithinolytica
*aRahnella aquatilis nbBacillus
thuringiensis
*aRahnella aquatilis *bBacillus cereus hPaenibacillus sp. aEnterobacter sp. *aKlebsiella oxytoca nbBacillus subtilis
*bBacillus anthracis naKlebsiella variicola *aRahnella aquatilis njEubacterium
moniliforme
nbLysinibacillus
sphaericus
nhPaenibacillus terrae hPaenibacillus sp. aEnterobacter sp. nhPaenibacillus
polymyxa
*bBacillus cereus *aKlebsiella oxytoca bBacillus sp. Uncultured
firmicutes
nkLactobacillus sp. aEnterobacter sp. naPectobacterium
carotovorum
aUncultured
enterobacter
naPantoea
rwandensis
*aKlebsiella
pneumoniae
*bBacillus cereus *bBacillus cereus Uncultured
bacterium
neClostridium
thiosulfatireducens
Uncultured
bacterium
bBacillus sp. naEnterobacter
cloacae
naPantoea
agglomerans
*aRahnella aquatilis *aKlebsiella
pneumoniae
Uncultured
bacterium
– neClostridium
xylanolyticum
Uncultured
actinobacterium
nlWeissella soli nhPaenibacillus
polymyxa
*aKlebsiella
pneumoniae
aEnterobacter sp. *aSalmonella
enterica
naKluyvera intermedia – hPaenibacillus sp. – Uncultured firmicutes naCitrobacter
freundii
nmBurkholderia
xenovorans
naKlebsiella variicola nfHerbaspirillum
frisingense
ngMycobacterium
chelonae
– eUncultured
clostridium
– Uncultured bacterium – npPseudomonas sp.
naLeclercia sp. naEnterobacter
cloacae
nhPaenibacillus sp. – nlWeissella soli – – – naPantoea vagans
bUncultured
bacillus
naEnterobacter
asburiae
niStreptomyces
leeuwenhoekii
– Uncultured bacterium – – – aKlebsiella sp.
cBacterium nxked5 eUncultured
clostridium
– – nlLeuconostoc
mesenteroides
– – – aPantoea sp.
nbBacillus
thuringiensis
eClostridium sp. – – bUncultured bacilli – – – Uncultured
bacterium
Uncultured
bacterium
cBacterium mj07 – – – – – – –
– naKosakonia
radicincitans
– – – – – – –
– cBacterium mj15 – – – – – – –
– cBacterium bx4 – – – – – – –
– Uncultured
bacterium
– – – – – – –
Polyherbal medicines were collected from the following: KWTa King Williamstown site A, KWTb King Williamstown site B, KWTc King Williamstown site C, AL Alice, EL East London, FB Fort Beaufort, HBft Hogsback first
treatment, HBst Hogsback second treatment, HBtt Hogsback third treatment
– absent, *pathogenic to human, a Enterobacteriaceae, b Bacilliaceae, n non-pathogenic, c unclassified bacteria, e Clostridiaceae, f Oxalobacteraceae, g Mycobacteriaceae, h Paenibacillaceae, i Streptomycetaceae,
j Eubacteriaceae, k Lactobacillaceae, l Leuconostocaceae, m Burkholderiaceae, p Pseudomonadaceae
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is an emerging human food-borne pathogen. B. cereus
has been reported to be associated with severe local and
systemic human infections such as endophthalmitis,
pneumonia, lung infections, bloody diarrhoea, gastro-
enteritis and meningitis, posing a serious public health
problem [40, 41]. The pathogenicity of B. cereus depends
on its ability to colonise, persist and subsequently invade
the host tissues [42]. The ability of this bacterium to
produce emetic toxins has been also associated with
gastro- and non-gastrointestinal infections [43].
B. anthracis is an obligate pathogen that infects many
vertebrates. It is the causative agent of anthrax. Anthrax
is an infectious disease that can infect humans in three
different ways, namely cutaneous anthrax, inhalation an-
thrax and gastrointestinal anthrax [44]. The presence of
this bacterium in the remedies could be due to the avail-
ability of its endospores in the soil where the herb ingre-
dients are harvested. The presence of Bacillus sp. in
these remedies poses great risks to the consumers.
Klebsiella species are Gram-negative, non-motile and
usually encapsulated rod-shaped bacteria [45]. Species
of this genus have been increasingly associated with
hospital infections [46]. They are common pathogens
of nosocomial pneumonia, septicaemia, urinary tract
infection, wound infections, intensive care unit infec-
tions and neonatal septicaemias [45]. K. pneumoniae, K.
oxytoca and K. variicola were detected in the remedies.
K. pneumoniae is the most pathogenic to humans.
Infections with this bacterium are usually hospital-
acquired. These include urinary tract infection, pneumo-
nia, intra-abdominal infection, bloodstream infection,
meningitis and pyogenic liver abscess [47]. K. pneumoniae
has been reported to posses several intrinsic and acquired
mechanisms which make it resistant to several antimicro-
bial agents [48, 49].
S. enterica was identified in KWTb remedy. It is a rod-
shaped, Gram-negative, flagellated facultative anaerobe.
The bacterium is a medically important pathogen of
both humans and animals. The presence of this bacter-
ium in this remedy is of concern because S. enterica is
known to cause diseases such as gastroenteritis, septi-
caemia and enteric fever clinically [50]. Like many other
infectious diseases, the infection severity of Salmonella
may vary depending on the resistance of individual to
the pathogen, the immune system and the virulence
strain [50].
Enterobacter species are rod-shaped, non-spore-forming,
facultative anaerobes and Gram-negative bacilli bacteria.
Several strains of these bacteria are increasingly been iden-
tified as nosocomial pathogens causing infections in hosts
with impaired immunity [51]. They have been reported to
cause 5 % of hospital-acquired septicemias, 5 % of nosoco-
mial pneumonias, 4 % of nosocomial urinary tract infec-
tions and 10 % of postsurgical peritonitis cases [52]. Skin
and soft tissue infection, endocarditis, intra-abdominal 
infection, septic arthritis, osteomyelitis and ophthalmic 
infection have been associated with these bacteria. E. 
cloacae is ubiquitous in nature, although generally not 
known to be an enteric pathogen; it is an opportunistic 
pathogen in humans [53, 54]. A wide spectrum of infec-
tions such as the urinary tract, lower respiratory tract, 
skin and soft tissue, biliary tract, wounds, intravenous 
catheters and the central nervous system have been 
associated with Enterobacter cloacae [55].
None of the analysed marketed polyherbal remedies 
had any form of food-based tests carried out on them 
since they are locally made medicines. This may prob-
ably account for the high discovery of bacterial popula-
tion in the remedies. The results from different findings 
conducted on microbial quality of traditional herbal 
medicines have been alarming revealing the presence of 
pathogenic bacteria and other contaminants in the 
herbal therapies [13–15, 17, 56]. Several fatal infectious 
outbreaks have been associated with the use of heavily 
contaminated raw materials of natural origin with patho-
gens; thus, great efforts are necessary to guarantee constant 
and adequate quality [57].
The prevalence of the members of Enterobacteriaceae in 
all the herbal remedies was recorded (Fig. 3.2). Entero-
bacteria are found in nature and are often thought as 
indicating faecal contamination. Thus, their presence 
could be regarded as an index of the degree of contam-
ination, which may indicate possible presence of harmful 
or disease causing organisms [58–60]. Also, higher num-
bers of spore-forming bacteria such as Bacillus sp. and a 
few numbers of Clostridium sp. found in the remedies 
could be due to the fact that some of these organisms 
produce spores which are resistant to harsh processing, 
elevated heat and dry conditions, thereby able to survive 
for a very long time on the products in dormant states 
[26]. Likewise, the members of Paenibacillaceae which 
are Gram-positive and are aerobic bacteria that are 
related to Bacilli were found in the remedies. Until re-
cently, these organisms were not known to cause human 
disease, but now, there are several reports of human 
infections caused by some members of this genus [61].
Conclusions
The findings of this study revealed different bacteria 
populations in the polyherbal medicines used for the 
treatment of tuberculosis in the Eastern Cape Province 
of South Africa; this is a cause for concern. Since there 
are no legislative criteria governing the microbial quality 
of these therapies in South Africa, there is an urgent 
need for the Government to take adequate control mea-
sures to set specific standards for quality of these medi-
cines, considering the fact that these medicines are being 
taking by immunocompromised individuals. Also, there is
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a need to educate the public as well as the traditional
healers in the Province, that proper hygienic condition
should be maintained in all preparation processes start-
ing from plant collection, processing, packaging and
storage, as well as emphasizing on the implications of
non-compliance to hygienic conditions to both the
consumers and the traditional healers.
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Fungal Metagenomes in Polyherbal Medicines used for the Treatment of Tuberculosis 
Abstract 
The traditional systems of medicine have significantly become more accepted in the 
developed and developing countries due to their curative property, less toxicity and minimal 
side effects. However, several studies have shown that they are associated with microbial 
contaminants. This study aimed at identifying fungi in nine polyherbal medicines used for the 
treatment of tuberculosis in Eastern Cape Province, South Africa. Sequences of fungi DNA 
that encodes internal transcribed spacer (ITS) region were retrieved from the remedies. The 
ITS region of the fungal rRNA operon was amplified using ITS1 and ITS4 primers. The 
amplicons were visualized on agarose gel electrophoresis, followed by end repair and adaptor 
ligation. They were further purified and quantified using Library Preparation kit NEBNext® 
UltraT DNA Library Prep Kit for Illumina and run on Illumina’s MiSeq platform. The study 
revealed that the polyherbal medicines are contaminated with fungi species. The predominant 
mycoflora obtained belongs to different genera or species of fungi. They include Aspergillus, 
Penicillium, Alternaria, Candida, Ramularia, Cladosporium and Malassezia among others. 
Some of these organisms are capable of causing infections in immunocompromised patients. 
Thus, the study identified various fungal contaminants in polyherbal remedies sold to 
tuberculosis patients in five communities in the Eastern Cape Province of South Africa.  
 
Key words: Fungi, ITS region, Polyherbal medicines, Public health, Tuberculosis 
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INTRODUCTION 
The use of polyherbal formulations for therapeutic purposes has significantly increased in the 
developed and developing countries because of their curative property, less toxicity and 
minimal side effects (Binu, 2008; Devi et al., 2010). These benefits have made the usage of 
herbal medicines to be intertwined with that of modern medicine, thus, increasing the global 
market by 7% annually (Dubey et al., 2008). Traditional healers, especially those in low-
income countries make use of various herbal preparations for the treatment and management 
of ailments such as wound infection, skin diseases, diabetes, diarrhoea, urinary tract 
infections, stomach illnesses and tuberculosis (Louw et al., 2002; Buwa and Afolayan, 2009).   
Tuberculosis (TB), caused by a bacterium called Mycobacterium tuberculosis is the 
major killer among the infectious diseases and it is the ninth-leading cause of death 
worldwide. An estimate of 10.4 million new TB cases was reported in 2016, of this 
population, 1.7 million deaths including human immunodeficiency virus-TB co-infected 
individual were recorded (WHO, 2017). Seven countries have been implicated to have the 
highest burden of TB cases, thus responsible for 64% of the world TB burden. These 
countries include India, Indonesia, China, Philippines, Pakistan, Nigeria and South Africa 
(WHO, 2017). According to the Statistics for South Africa, TB is a significant public health 
challenge accounting for 7.2% of all death in 2016 followed by diabetes mellitus (SSA, 
2017). The report of WHO (2016) gave an estimated incidence of 454,000 cases of active TB 
in South Africa; this implies that, about 0.8% of the 54 million South Africa populations 
develop active TB diseases (WHO, 2016). 
 In South Africa, about three million people make use of herbal remedies for their 
health care purposes especially for the treatment of infection disease such as TB (Louw et al., 
2002; Elujoba et al., 2005). Despite the increasing use of herbal preparations and the global 
expansion of the market, safety is of great concern. Some studies have revealed that due to 
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unscientific mode of harvesting, drying, transportation, cleaning and handling of these herbal 
preparations, the raw plants prone to infestations and exposed them to different kinds of 
microbial contaminants (Stevic et al., 2012). The dominating contaminants are the bacterial 
endospores and fungal spores with the remaining are heavy metals and viruses originating 
from the soil (Adeleye et al., 2005; Kaume et al., 2012; Ting et al., 2013; Noor et al., 2014).  
A few surveillance studies (Czech et al., 2001; Tassaneeyakul et al., 2004; Okunlola 
et al., 2007; Kulshrestha et al., 2008) have been conducted and have shown the presence of 
microbial contaminants in herbal preparations. Walther et al. (2016) investigated 109 
traditional liquid herbal medicinal products in Mwanza city, the findings revealed that 81.7% 
of the samples were contaminated with fecal coliforms. The microbial quality of some oral 
liquid herbal medicines marketed in Ile-Ife conducted showed that 90% of the samples 
carried microbial loads beyond officially permissible limits (Igbeneghu and Lamikanra, 
2016). Also, the quality control of hypoglycemic herbal preparations in Nairobi investigated 
have shown that the preparations are contaminated with both bacterial and fungal 
contaminants (Chege et al., 2015). 
Siakrwar et al. (2014) isolated and identified a wide spectrum of fungi including 
Aspergillus, Penicillium, Alternaria, Rhizopus and Syncephalastrum species 15 medicinal 
plants. Toma and Abdulla, (2013) found that most of the fungal species detected in different 
types of spices and medicinal plants were Aspergillus spp. and Penicillium spp. while 
Stachybotrys sp., Syncephalastrum racemocum, Uocladium botrytis, Alternaria alternata, 
Cladosporium lignicolum and Gliocladium catenulatum were less frequently detected. 
Quality assessment of aqueous herbal/medicinal products has shown that the most abundant 
fungi were from Cladosporium herbarum. This was then followed by Aspergillus spp., 
Saccharomyces kluyverii, Rhodotorulla minuta, Candida membranifasciens and 
Sporobolomyces salmonicolor (Osei-Adjei et al., 2013).  
51 
The presence of numerous fungal species in herbal preparations can be harmful to 
consumers. Thus, in other to safe guard the health of the consumers, this study aimed at 
identifying the presence of different fungi in polyherbal medicines used for the treatment of 
tuberculosis in Amathole District Municipality, Eastern Cape Province, South Africa.  
MATERIALS AND METHODS 
Sample collection 
This study is a secondary data analysis of the first authors’ research project “Ethno-medicinal 
documentation of polyherbal medicines used for the treatment of tuberculosis in Amathole 
District Municipality of the Eastern Cape Province, South Africa” where information about 
the herbs used for the preparation of this remedies are revealed (Famewo et al., 2017). A total 
of nine different polyherbal medicines were purchased from the traditional herbal healers in 
five different communities namely; East London (EL), King Williams Town (KWT), 
Hogsback (HB), Alice (AL) and Fort Beaufort (FB) as shown in Figure 4.1. These remedies 
were liquid preparations and each of them was already homogenized and packaged in a 2 
liters container by the herbal healers. Each remedy was labelled and coded according to the 
place of collection. The number of remedies obtained in this study was due to the fact that 
only a few traditional healers treat and sell the remedies for the treatment of tuberculosis. 
They claim to have acquired the knowledge from their ancestors, and this knowledge is being 
transferred from one generation to another. The samples were transported to Medicinal Plants 
and Economic Development (MPED) Research Centre Microbiology Laboratory for analysis. 
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Figure 4.1. Map of Amathole District Municipality (Famewo et al., 2016) 
DNA extraction 
A modified method of Dei-Tutuwa et al. (2014) was used for the fungal DNA extraction. One 
ml of each sample was pipetted into Eppendorf tubes and centrifuged at 12500 rpm for 10 
mins, the supernatant was discarded and the cell pellets was collected. The total fungal DNA 
was extracted using ZR Fungal/Bacterial DNA MiniPrepTM Kit (Zymo Research, USA) 
according to the manufacturer instructions. 
Amplification of fungal DNA using polymerase chain reaction (PCR)  
The assay was conducted using the internal transcribed spacer (ITS) region of the fungal 
genome which is highly variable among species or even populations of the same species 
(Schoch  et al., 2012). This region lies between the 18S small subunit (SSU) and 28S large 
subunit (LSU) ribosomal RNA (rRNA) genes, which also contains two non-coding spacer 
regions (ITS-A and ITS-B) separated by the 5.8S rRNA gene. The total genomic fungal DNA 
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was amplified using forward ITS1 (5’-TCCGTAGGTGAACCTGCGG-3’) and reverse 
primers ITS4 (5’-TCCTCCGCTTATTGATATGC-3’) (White et al., 1990). PCR reaction was 
carried out in a final volume of 25 μL consisting England Biolabs, USA 5 μL template DNA, 
12.5 μL of Q5 ® Hot start High-Fidelity 2X PCR Master Mix (New), 1 μL of 10 pmol  each 
of the oligonucleotide primers (Inqaba Biotech, SA) and 5.5 μL of nuclease free water). 
Reactions were performed in the thermocycler (Bio-Rad Mycycler, USA) under the following 
conditions: initial denaturation at 95 °C for 2 min, followed by 30 cycles at 95 °C for 20 sec, 
55 °C for 30 sec, and 72 °C for 30 sec, and a final elongation at 72 °C for 5 min (Kuo et al. 
2005). In order to confirm the PCR products size, 5 µl of the amplicons was analyzed by gel 
electrophoresis in 1% agarose (Merck, SA) stained with 3 µl ethidium bromide (Sigma-
Aldrich, USA). A 100 bp DNA ladder (Thermo Scientific, (EU) Lithuania was included for 
band size estimation purposes. All gels were run in 0.5X TBE buffer at 95 V for 1 h and 
visualized by UV trans-illumination (Alliance 4.7, France).  
Purification of amplicons and sequencing 
The amplicons were purified using the Agencourt® Ampure® XP bead protocol (Beckman 
Coulter, USA). The amplicon libraries were purified using the Agencourt® Ampure® XP bead 
protocol (Beckman Coulter, USA). Library concentration was measured using Nebnext 
Library quant kit (New England Biolabs, USA) and quality validated using Agilent 2100 
Bioanalyser (Agilent Technologies, USA). The samples were pooled in equimolar 
concentrations and diluted to 4nM based on library concentrations and calculated amplicon 
sizes. The library pool was sequenced on a MiSeqTM (Illumina, USA) using a MiSeqTM 
Reagent kit V3 600 cycles PE (Illumina, USA). The final pooled library was at 10pM with 
20% PhiX as control amplicon sequencing protocol. Each sample was sequenced in the sense 
and antisense directions using ITS1 and ITS4 primers (White et al., 1990; Kozich et al., 
2013). 
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Data analysis 
The relative frequency of different fungal phylum in each of the remedy, percentage 
occurrence of each fungal family and the abundance of fungal families was calculated 
according to Girridher and Ready (1997). 
% of frequency = Number of observation in which a species appeared X100 
Total number of observation 
RESULTS 
Distribution of different fungal phylum in each of the polyherbal remedies 
The mycological analysis of the nine polyherbal remedies revealed that all the herbal 
preparations are contaminated with different fungal phylum and species. The predominant 
fungal phylum identified in all the herbal remedies was Ascomycota followed by 
Basidiomycota. The presence of 5% Glomeromycota was identified in KWTb and 
HBss remedies while 5% Zygomycota was found in KWTc remedy (Figure 4.2).  
Figure 4.2. Relative frequencies of contaminating organisms in each of the polyherbal 
remedy 
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Distribution of different fungal families in all the polyherbal remedies 
A total of 43 different fungal families were identified in all the nine polyherbal remedies. 
Members of the families Davidiellaceae, Mycosphaerellaceae, Trichocomaceae, 
Pleosporaceae and Saccharomycetaceae were identified in all the remedies (Figure 4.3). 
This was followed by Debaryomycetaceae, Malasseziaceae, Dothioraceae, 
Herpotrichiellaceae and Tremellaceae. 
The abundance of each fungal family in all the remedies is represented in Figure 
4.4 below. Members of the family Trichocomaceae were the most abundant followed 
by Mycosphaerellaceae, Pleosporaceae, Saccharomycetaceae, Tremellaceae, 
Davidiellaceae, Malasseziaceae and Sporidiobolaceae. 
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Figure 4.3.  Percentage occurrence of each fungal family identified in the polyherbal remedies 
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Figure 4.4. The abundance of fungal families in all the polyherbal remedies 
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Distribution of different fungal genera and species in each of the polyherbal remedies 
By analyzing each of the herbal preparation (supplementary material), KWTa remedy was 
mainly contaminated with species of Debaryomyces, Penicillium and Ramularia. However, 
Rhodotorula, Cladosporium, Ramularia, Candida and Malassezia species were found in 
KWTb remedy. The remedy from KWTc was contaminated with Ramularia, Candida, 
Cryptococcus, Rhodotorula, Cystofilobasidium and Mucor species.  
While AL remedy was mostly dominated with Ramularia, Aspergillus, Penicillium, 
Candida, Rhinocladiella and Parmotrema species; Cladosporium, Ramularia, Alternaria, 
Candida and Malassezia were identified in EL remedy. The presence of Cladosporium, 
Ramularia, Aspergillus, Penicillium, Alternaria and Candida were detected in FB remedy. 
While species of Cladosporium, Ramularia, Aspergillus and Penicillium dominated 
the mycofloral of HBfs remedy, HBss remedy was contaminated with Cladosporium, 
Ramularia and Aspergillus. However, Cladosporium, Ramularia, Aspergillus, Penicillium, 
Alternaria and Wallemia species were detected in HBts remedy. 
Across all the herbal remedies, the most predominant mycoflora obtained was 
distributed in four different genera which comprised of Candida, Cladosporium, Ramularia 
and Alternaria. This was followed by Aspergillus and Penicillium which were found in seven 
and eight remedies, respectively (supplementary material). 
DISCUSSION 
The use of polyherbal medicines for the treatment and management of various illnesses is part 
of the health-care culture in South Africa. These remedies are prepared locally by traditional 
healers by combining two or more parts of medicinal plants such as the root, leaf, stem, flower 
and seed. The results obtained in the present study revealed the presence of different fungi 
contaminants particularly moulds and yeast in the polyherbal remedies, which are used for the 
59 
treatment of TB. The presences of these organisms may pose potential health risks to 
tuberculosis patients considering their immunocompromised status. The high fungal 
population in each of the remedies is an indication of low environmental sanitation and 
unhygienic standard of processing these herbal medicines. All the remedies were stored at 
room temperature in the shops and there were no expiry date written on them, thus, the 
storage condition could have encouraged the growth of these fungal species.   
Many of the fungal species identified are naturally inhabitant of the soil and some are 
plant pathogens. According to Sharma (2001), fungal contamination of herbal preparations 
mainly occurs during a slow drying process. Inadequate drying or postharvest storage of the 
herbs under a high relative humidity and favourable temperature promotes the growth of these 
microbes (Sharma, 2001). Also, the unscientific methods of collection, unsuitable 
transportation and prolonged storage of the plants and inadequate hygiene of the handler could 
trigger the growth of organisms in herbal medicines (Sago et al., 2009; Stević et al., 2012).  
The presence mould such as Aspergillus and Penicillium species in seven and eight 
polyherbal remedies, respectively, could be attributed to the growth of these organisms in the 
herbs before the medicinal plants were completely dried (Stevic et al., 2012). Both species of 
Aspergillus and Penicillium have been associated with food poisoning and may cause 
infections in an immunosuppressed individuals (Lin and Teutsch, 2001; Bateman et al., 2002). 
The results of this study were in well agreement with those found by Tournas and Katsoudas 
(2008). The study examined the microbiological quality of various medicinal herbal teas. The 
findings revealed that the most common fungal contaminants in the herbal teas were 
Aspergillus niger, Penicillium spp., Eurotium rubrum, E. chevalieri, A. flavus, Fusarium spp., 
Alternaria alternata and yeasts. Also, a South African study has reported contamination of 
herbal products with bacteria as well as fungi such as Penicillium and Aspergillus (Govender 
et al., 2006). Examination of pathogenic microorganisms in medicinal herbal drugs has 
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equally shown that the most abundant fungi species were from Fusarium, Aspergillus and 
Alternaria according to Stevic et al. (2012). In addition, the fungal contamination of 
powdered herbal medicinal preparations sold in some parts of Nigeria was evaluated, the 
results showed that all of the herbal preparations had the presence of fungal contaminants with 
predominance of Aspergillus spp. and Penicillium spp., while Mucor spp., Candida spp. and 
Trichosporium spp., were also present (Anyanwu, 2010). Similar to this study, is the findings 
of Zheng et al. (2017) which revealed that the surface of medicinal herbs are predominantly 
contaminated with species of Aspergillus and Penicillium. 
Aspergillus is a group of moulds found in natural environment, it is an airborne fungus 
capable of causing Aspergillosis. Species of this genus are highly aerobic, possesses the 
ability to grow where high osmotic pressure exist and are found in oxygen rich environment. 
They are capable of growing at low water content; thus, to avoid their growth, quick drying of 
the herbs are highly important (Stevic et al., 2012). There species are detectable in the ground, 
air and in plants. Aspergillus does not normally cause infection except in an 
immunocompromised individuals such as leukaemia, asthma, HIV/AIDS and in people with 
damaged lungs due to TB infection, thus causing severe pulmonary disease (WHO, 2011). 
According to WHO Bulleting, about one-third of TB patients develop cavities in their lungs, 
thus making them vulnerable to the infection (WHO, 2011). The presence of this Aspergillus 
in the remedies could be detrimental to the health of TB-patients considering their 
immunosuppressed status.  
Species of Fusarium were also detected in four of the remedies. In a study carried out 
by Stevic et al. (2012), Fusarium was observed as the most dominant genus in most of the 
herbal drugs tested. The spores of this organism can survive drying conditions and remain 
dormant for several months. They are found abundantly in the soil and many of them are 
important plant pathogens causing various diseases such as crown rot, head blight and scab on 
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cereal grains (Nelson et al., 1994). Some strains such as Fusarium fumonisins and F. 
trichothecenes are toxins producers; however, they were not identified in these remedies. 
Several species of Fusarium have emerged as important opportunistic pathogens in humans 
causing a broad spectrum of infections such as hyalohyphomycosis, mycotic keratitis, 
onychomycosis, pneumonia, disseminated infections and sinusitis mostly in 
immunocompromised patients (Makowsky et al., 2005; Guarro, 2013). Species of Fusarium 
identified in this study are F. oxysporum, F. verticillioides and F. delphinoides. Many studies 
have reported cases of Fusariosis in patients with acute myeloid and lymphoblastic leukemia 
(Jossi et al., 2010) however; there is dearth information on Fusarium infections associated 
with tuberculosis patients. Considering the immune-deficiency of the patients, the 
consumption of these remedies over a long period and prolong storage should be avoided in 
order to prevent the production of mycotoxins in the remedies. 
Alternaria, Candida and Ramularia species were also found in all the tested remedies. 
Alternaria species are plant pathogens and field mycotoxin-producing moulds (Stevic et al., 
2014). They are capable of producing tenuazonic acid and other toxic metabolites which may 
be associated with diseases in humans or animals. These organisms have been reported as 
causative agents of subcutaneous phaeohyphomycosis, mycotic keratitis, hypersensitivity 
pneumonitis and extrinsic asthma (Crissey et al., 1995). They equally cause infections such as 
allergic bronchopulmonary mycosis and pheohyphomycotic lumbar spondylodiscitis in 
immunocompromised individuals. Therefore, it is important to maintain these remedies at the 
temperature or condition that would not support the growth this organism.  
Candida species are yeasts and the most common cause of global fungal infections 
called Candidiasis (Manolakaki et al., 2010). They are commensals that colonize the skin, 
gastrointestinal and reproductive tracts. The species of Candida identified in this study are 
non-pathogenic strains but are capable of causing infections in immunocompromised patients. 
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Species of these organisms have been reported as emerging pathogenic fungal in patients with 
pulmonary tuberculosis (Kali et al., 2013; Ndukwu et al., 2016). Since Candida species can be 
found on the skin, coupled with the unsterile mode of preparation of these remedies, it could 
be said that this organism was introduced into the remedies by the handler during the process 
of preparation. The presence of these fungal contaminants in the polyherbal remedies can 
reduce or inactivate the therapeutic activity of the remedies and possess the potential to 
adversely affect the tuberculosis patients.   
Conclusion 
The findings of this study indicated that polyherbal medicines marketed in the study area are 
contaminated with fungi contaminants. Some of these organisms are capable of causing 
infections in immunocompromised patients while others are plant pathogens. The 
contamination of these polyherbal preparations could have resulted from contaminated soil, 
plants, inadequate drying, unhygienic mode of preparation and possibly prolonged storage. 
This could probably be a potential health risk to consumers. It is therefore suggested that 
quality-control measures and safe handling practices be established for medicinal herbs in the 
Province. 
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Families KWTa KWTb KWTc AL EL FB HBfs HBss HBts 
Davidiellaceae Cladosporium 
tenuissimum 
Uncultured 
cladosporium 
Uncultured 
cladosporium 
Cladosporium 
cladosporioides 
Cladosporium 
cladosporioides 
Cladosporium 
cladosporioides 
Cladosporium 
cladosporioides 
Davidiella tassiana Cladosporium sp. 
Cladosporium 
cladosporioide 
Cladosporium sp. Cladosporium 
sphaerospermum 
Cladosporium 
cladosporioides 
Davidiella tassiana 
Cladosporium 
sphaerospermum 
Mycosphaerellaceae Ramularia eucalypti Ramularia eucalypti Ramularia eucalypti Ramularia mali Ramularia eucalypti Ramularia mali Cladosporium herbarum Ramularia eucalypti Ramularia eucalypti 
Ramularia mali Ramularia mali Ramularia mali Ramularia eucalypti Ramularia mali Ramularia eucalypti Cercospora sojina Ramularia mali Ramularia mali 
Cladosporium 
herbarum 
Cladosporium 
herbarum 
Ramularia vizellae Cladosporium 
herbarum 
Ramularia mali Cladosporium 
herbarum 
Cladosporium herbarum 
Ramularia vizellae Cercospora sp. Ramularia eucalypti Cladosporium 
sphaerospermum 
Cercospora sojina 
Debaryomycetaceae Debaryomyces 
hansenii 
Meyerozyma 
guilliermondii 
Meyerozyma 
guilliermondii 
Meyerozyma 
guilliermondii 
Debaryomyces 
hansenii 
Meyerozyma 
guilliermondii 
Debaryomyces hansenii Debaryomyces 
nepalensis 
Meyerozyma 
guilliermondii 
Meyerozyma 
guilliermondii 
Debaryomyces 
hansenii 
Debaryomyces 
macquariensis 
Trichocomaceae Aspergillus niger Talaromyces 
amestolkiae 
Aspergillus 
pseudoglaucus 
Aspergillus 
pseudoglaucus 
Penicillium sp. Aspergillus steynii Aspergillus 
pseudoglaucus 
Aspergillus niger Aspergillus 
pseudoglaucus 
Penicillium 
commune 
penicillium 
brevicompactum 
Aspergillus 
fumigatus Aspergillus 
westerdijkiae 
Talaromyces 
amestolkiae 
Aspergillus 
pseudoglaucus 
Penicillium 
chrysogenum 
Table 1: Supplementary Material: Identified fungal families, genera and species in all the polyherbal 
64 
Penicillium 
crustosum 
Talaromyces 
amestolkiae 
Aspergillus 
amstelodami 
Aspergillus 
pseudoglaucus 
Penicillium oxalicum Talaromyces 
amestolkiae 
Aspergillus ruber 
Aspergillus ruber Talaromyces 
amestolkiae 
Aspergillus ruber Penicillium 
commune 
Aspergillus 
amstelodami 
Penicillium 
verrucosum 
Aspergillus 
amstelodami 
Aspergillus 
amstelodami 
Aspergillus ruber Talaromyces 
amestolkiae 
Penicillium 
chrysogenum 
Aspergillus 
proliferans 
Penicillium commune Penicillium 
brevicompactum 
Penicillium 
brevicompactum 
Aspergillus 
versicolor 
Penicillium steckii 
Aspergillus ruber Aspergillus 
appendiculatus 
Penicillium 
chrysogenum 
Aspergillus nomius 
Penicillium 
brevicompactum 
Aspergillus 
ostianus 
Penicillium 
commune 
Pleosporaceae Alternaria alternata Alternaria alternata Alternaria alternata Alternaria alternata Stemphylium sp. Alternaria sp. Alternaria alternata Epicoccum nigrum Alternaria porri 
Leptosphaerulina 
chartarum 
Alternaria alternata Alternaria alternata Stemphylium sp. Alternaria alternata Alternaria alternata 
Phoma sp. Epicoccum nigrum Alternaria 
tenuissima 
Phoma sp. Phoma plurivora 
Pyrenophora tritici- Alternaria japonica Paraconiothyrium 
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repentis sp. 
Bipolaris 
cynodontis 
Saccharomycetaceae Candida intermedia Candida oleophila Candida oleophila Candida 
parapsilosis 
Candida sp. Pichia kudriavzevii Candida etchellsii Candida sp. Candida orthopsilosis 
Candida intermedia Candida railenensis Candida oleophila Candida zeylanoides Candida intermedia Pichia fermentans 
Yamadazyma 
triangularis 
Candida etchellsii 
Candida oleophila 
Malasseziaceae Malassezia globosa Malassezia restricta Malassezia globosa Malassezia restricta Malassezia restricta Malassezia restricta Malassezia restricta 
Malassezia restricta Malassezia 
sympodialis 
Malassezia 
sympodialis 
Dothioraceae Aureobasidium 
pullulans 
Aureobasidium 
pullulans 
Aureobasidium 
pullulans 
Rhodotorula sp. Aureobasidium 
pullulans 
Aureobasidium 
pullulans 
Arxiella dolichandrae 
Aureobasidium 
pullulans 
Herpotrichiellaceae Rhinocladiella similis Exophiala bergeri Rhinocladiella 
similis Phialophora mustea 
Rhinocladiella 
similis Rhinocladiella similis 
Rhinocladiella 
atrovirens 
Phialophora mustea 
Tremellaceae Cryptococcus 
amylolentus 
Cryptococcus 
laurentii 
Cryptococcus 
heimaeyensis 
Cryptococcus 
albidosimilis 
Kwoniella 
mangrovensis 
Cryptococcus zeae 
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Kwoniella heveanensis Cryptococcus 
albidosimilis 
Cryptococcus 
albidosimilis 
Cryptococcus sp. Cryptococcus 
albidosimilis 
Kwoniella 
mangrovensis 
Cryptococcus 
adeliensis 
Bullera dendrophila Bullera dendrophila 
Metschnikowiaceae Clavispora lusitaniae Clavispora lusitaniae Clavispora 
lusitaniae 
Metschnikowia 
corniflorae 
Clavispora 
lusitaniae 
Cryptococcus 
albidosimilis 
Metschnikowia 
pulcherrima 
Sporidiobolaceae Sporidiobolales sp. Rhodotorula 
mucilaginosa 
Rhodotorula 
mucilaginosa 
Rhodotorula 
mucilaginosa 
Rhodotorula 
mucilaginosa 
Rhodotorula 
fujisanensis 
Rhodotorula colostri 
Rhodotorula 
mucilaginosa 
Rhodotorula 
fujisanensis 
Rhodosporidium 
babjevae 
Nectriaceae Fusarium oxysporum Fusarium delphinoides Fusarium 
verticillioides 
Gibberella pulicaris Fusarium oxysporum 
Pichiaceae Pichia fermentans Issatchenkia 
hanoiensis 
Issatchenkia 
hanoiensis 
Yamadazyma 
triangularis 
Clavicipitaceae Metarhizium 
flavoviride 
Metarhizium 
flavoviride 
Metarhizium 
flavoviride Metarhizium flavoviride 
Leucosporidiaceae Leucosporidium 
scottii 
Uncultured 
leucosporidium 
Uncultured 
leucosporidium 
Leucosporidium scottii 
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Clavariaceae Uncultured 
clavulinopsis 
Uncultured 
clavulinopsis 
Uncultured 
clavulinopsis 
Plectosphaerellaceae Plectosphaerella 
cucumerina 
Uncultured 
gibellulopsis Gibellulopsis nigrescens 
Gibellulopsis 
nigrescens 
Psathyrellaceae Coprinopsis 
episcopalis 
Coprinellus sp. 
Peniophoraceae 
Peniophora sp. Peniophora sp. Peniophora sp. 
Peniophora 
incarnata 
Polyporaceae Trametes sanguinea Daedaleopsis sp. 
Pycnoporus 
coccineus 
Phanerochaetaceae Phanerochaete 
sordida Phanerochaete sordida 
Wallemiaceae Wallemia sebi Wallemia mellicola 
Wallemia sebi 
Wallemia muriae 
Filobasidiaceae Filobasidium 
elegans 
Filobasidium elegans 
Filobasidium 
floriforme 
Filobasidium floriforme 
68 
Ophiostomataceae Ophiostoma ips Cystofilobasidium 
capitatum 
Diversisporaceae Uncultured 
diversispora 
Cyfstofilobasidiaceae Cystofilobasidium 
ferigula 
Guehomyces 
pollulans 
Cystofilobasidium 
capitatum 
Mucoraceae Mucor circinelloides 
Mucor fragilis 
Valsaceae Cytospora 
austromontana 
Ceratocystidaceae Ceratocystis 
paradoxa 
Microascales sp. 
Cordycipitaceae  Lecanicillium 
psalliotae 
Parmeliaceae Parmotrema 
austrosinense 
Parmotrema 
tinctorum 
Wickerhamyceteae Wickerhamomyces 
anomalus 
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Amphisphaeriaceae Pestalotiopsis 
disseminata 
Pleurostomataceae Pleurostomophora 
richardsiae 
Microascaceae Sphaeronaemella 
fimicola 
Pseudallescheria 
boydii 
Phyllachoraceae Uncultured phyllachora 
Phyllachorales sp. 
Xylariaceae Sordariomycetes sp. 
Xylaria sp. 
Gymnoascaceae Uncultured 
gymnoascus 
Glomeraceae Uncultured glomus 
Marasmiaceae Marasmiellus 
violaceogriseus 
Atheliaceae Piloderma sp. 
Dermateaceae Gloeosporium sp. 
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Abstract
Background: The emergence of  drug-resistant strains of  Mycobacterium tuberculosis has become a global public health problem. 
Polyherbal medicines offer great hope for developing alternative drugs for the treatment of  tuberculosis.
Objective: To evaluate the anti-tubercular activity of  polyherbal medicines used for the treatment of  tuberculosis.
Methods: The remedies were screened against Mycobacterium tuberculosis H37Rv using Middlebrook 7H9 media and MGIT BAC-
TEC 960 system. They were liquid preparations from King Williams Town site A (KWTa), King Williams Town site B (KWTb), 
King Williams Town site C (KWTc), Hogsback first site (HBfs), Hogsback second site (HBss), Hogsback third site (HBts), East 
London (EL), Alice (AL) and Fort Beaufort (FB).
Results: The susceptibility testing revealed that all the remedies contain anti-tubercular activity with KWTa, KWTb, KWTc, 
HBfs, HBts, AL and FB exhibiting more activity at a concentration below 25 µl/ml. Furthermore, MIC values exhibited in-
hibitory activity with the most active remedies from KWTa, HBfs and HBts at 1.562 µg/ml. However, isoniazid showed more 
inhibitory activity against M. tuberculosis at 0.05 µg/ml when compare to the polyherbal remedies.
Conclusion: This study has indicated that these remedies could be potential sources of  new anti-mycobacterial agents against 
M. tuberculosis. However, the activity of  these preparations and their active principles still require in vivo study in order to assess
their future as new anti-tuberculosis agents.
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Introduction
Mycobacterium tuberculosis, the leading causative agent of  
tuberculosis (TB) is responsible for the morbidity and 
mortality of  a large population worldwide1. TB has a long 
co-evolutionary history with humans. It does not exhibit 
any symptom of  disease except when impairment of  im-
munity arises due to malnutrition, diabetes, malignancy 
and AIDS2; however, about 10% of  healthy individuals 
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may develop active TB in their life time due to genet-
ic factors. The ability of  TB to resist drugs and the in-
fluence of  HIV epidemic has made the disease remain 
a devastating global public health problem3. According 
to WHO4, one-third of  the world’s population have been 
infected with Mycobacterium tuberculosis (MTB). In 2014, an 
estimated number of  9.6 million new TB infections were 
reported, of  which 5.4 million were men; 3.2 million were 
women and 1.0 million children3. This disease is responsi-
ble for approximately two million deaths annually5.
Some of  the main obstacles to the global control of  the 
disease are the HIV epidemic that has dramatically in-
creased the risk of  developing active TB, increasing emer-
gence of  multidrug resistant-TB (MDR-TB: resistance to 
isoniazid and  rifampin) and refractory nature of  latent 
TB treatment to conventional anti-TB drugs6,7,8,9. The sit-
uation is further exacerbated by the increasing develop-
ment of  extensively drug-resistant (resistant to MDR-TB, 
all fluoroquinolones and at least one of  the second-line 
anti-TB injectable drugs including amikacin, kanamycin 
and/or capreomycin)10,11. According to the modes of  
action of  these drugs, they can be grouped as cell wall 
inhibitors (isoniazid, ethambutol, ethionamide, cycloser-
ine), nucleic acid synthesis inhibitors (rifampicin and 
quinolones), protein synthesis inhibitors (streptomycin, 
kanamycin) and inhibitors of  membrane energy metab-
olism (pyrazinamide)12,13,14. For instance, Isoniazid (INH 
)is the most widely used treatment for TB and its latent 
infections15. This drug enters the cell as a pro-drug, which 
is activated by MTB catalase-peroxidase enzyme (KatG). 
The enzyme activates INH and facilitates its interaction 
with various toxic reactive species (oxides, hydroxyl rad-
icals and organic moieties) in the bacterial cell16, thereby, 
weakening the components of  the cell wall and finally, 
the death of  the bacteria17. INH targets inhA enzyme 
(enoylacyl carrier protein reductase), which is involved in 
the elongation of  fatty acids in mycolic acid synthesis18. 
The replacement of  an amino acid in the NADH binding 
site of  inhA results into INH resistance, preventing the 
inhibition of  mycolic acid biosynthesis19. INH-resistant 
strains often lose catalase and peroxidase activities due to 
KatG Ser315Thr mutation20. Resistance to INH can also 
occur through mutations in the promoter region of  inhA, 
leading to over expression of  inhA, or by mutations at the 
inhA active site, thereby lowering inhA affinity for INH21.
Rifampicin (RIF) have been used as first-line drug in com-
bination with other therapies for the treatment of  TB in-
fections. RIF is believed to inhibit bacterial DNA-depen-
dent RNA polymerase9. This drug interferes with RNA 
synthesis by binding to the β subunit of  mycobacterial RNA 
polymerase, which is encoded by rpoB, thereby killing 
the organism. Resistance to RIF arises due to missense 
mutations in the gene. Mtb resistance to RIF occurs at 
a frequency of  10−7 to 10−8 as a result of  mutations 
in rpoB22. About 96% of  all mutations are found in the 
81-bp core region of  the gene between codons 507 and
533, with the most common changes occurring in codons
Ser531Leu,His526Tyr and Asp516Val23.
Pyrazinamide (PZA) is another vital first-line drug used 
for the treatment of  TB. It plays an important role in re-
ducing the duration of  TB treatment24. PZA is a pro-drug 
that requires conversion to its active form, pyrazinoic acid 
(POA) by the mycobacterial enzyme pyrazinamidase/nico-
tinamidase. The efflux system of  the mycobacterial cell 
enables massive accumulation of  POA in the bacterial cy-
toplasm, leading to disruption of  the bacterial membrane 
potential25,26. The exact mechanism of  PZA resistance 
remains unknown9. However, PZA resistance has been 
associated with defective pyrazinamidase/nicotinamidase 
activity which results from mutations that might occur at 
different regions (3-17, 61-85 and 132-142) of  pyrazin-
amidase/ nicotinamidase27.
Ethambutol (EMB) is a first-line drug used in combina-
tion with INH, RIF and PZA preventing the emergence 
of  drug resistance mycobacterium. This drug interferes with 
the cell wall of  MTB through a synthetic mechanism 
thereby inhibiting arabinosyl-transferase (embB), an en-
zyme involved in cell wall biosynthesis28. The enzyme 
has been proposed as the target of  EMB in Mtb11. Mu-
tation is the cause of  EMB resistance and it occurs at a 
rate of  approximately 1 in 107 organisms. It increases the 
production of  arabinosyl-transferase, which overwhelms 
the inhibitory effects of  EMB. Studies have revealed five 
mutations in codon 306 accounting 70–90% of  all EMB 
resistant strains29. The resistance of  Mtb to TB-drugs 
is mostly due to mutation which is a cause for concern. 
Therefore, it is important to search for new anti-tuberculo-
sis agents, preferably those that can be readily and simply 
produced from medicinal plants.
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It has been estimated that about 80% of  South African 
population is infected with tuberculosis, with 88% high-
est prevalence of  latent TB among the age group of  30-
39 years old living in the rural settlements30. However, 
the strains of  drug resistant tuberculosis have been on 
increase yearly in the country31.
Polyherbal remedies have been used extensively for the 
treatment of  various diseases for many centuries. They 
are mixtures of  various herbs which contain multiple 
active constituents and act synergistically against infec-
tions32. Natural products and/or their semi-synthetic 
derivatives are important sources of  new chemical com-
pounds that might play an important role in the chemo-
therapy of  tuberculosis33. Several studies on the use of  
polyherbal medicines have revealed that these therapies 
possess pharmacological functions. For instance, Rajanya-
malakadi, a polyherbal preparation which contains three 
herbal ingredients has been proven to show significant 
anti-diabetic, hypolipidemic and anti-oxidant properties34. 
Also, Polyherbal health tonic tea used for the treatment 
of  an array of  diseases affecting humans and Sanjivani 
Vati used for the treatment of  cough and cold have been 
shown to possess significant pharmacological activi-
ties35,36. Other Polyherbal remedies such as Livina, Rhuma-
par tablet, Diakyur and Sugar Remedy have been proven 
to contain pharmacological activities37,38,39,40.
Many researchers have reported on the inhibitory prop-
erties of  medicinal plants against Mycobacterium tuberculosis 
both in South Africa and in other countries33,41,42 but there 
is a dearth of  information on the inhibitory properties 
of  polyherbal medicines against this organism. The aim 
of  the present study therefore was to evaluate polyherbal 
remedies used for the treatment of  TB for anti-Mycobacte-
rium tuberculosis activities.
Materials and methods
Collection of  polyherbal medicines
A total of  nine polyherbal medicines evaluated in this 
study were purchased from herbal sellers in five com-
munities namely; Alice, Fort Beaufort, Hogsback, King 
Williams Town and East London in Amathole District 
Municipality of  the Eastern Cape Province, South Africa 
(Figure 1). Each remedy was labelled and coded according 
to the place of  collection; viz: King Williams Town site A 
(KWTa), King Williams Town site B (KWTb), King Wil-
liams Town site C (KWTc), Hogsback first site (HBfs), 
Hogsback second site (HBss), Hogsback third site (HBts), 
East London (EL), Alice (AL) and Fort Beaufort (FB). 
The small number of  remedies obtained in this study was 
due to the fact that only a few traditional healers treat 
and sell remedies for TB. They claim to have acquired 
the knowledge from their ancestors; and this knowledge 
is been transferred from one generation to another.  The 
herbal ingredients present in each of  the remedies are 
shown in Table 1. The remedies were already prepared 
with water by the herbal sellers into clean 2-litre contain-
ers. They were then transported to Medicinal Plants and 
Economic Development Research Centre, University of  
Fort Hare for analysis.
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Figure 1: Map of Amathole District Municipality43
Table 1: Herbal ingredients present in each of the polyherbal medicines used for the 
treatment of tuberculosis in Amathole district municipality, 
Eastern Cape Province, South Africa 
Source: Famewo et al. (44)
Name/code Local name Botanical name Parts 
used
AL Mountain garlic
Mlomo mnandi
Red carrot
Inongwe
Mnonono
River pumpkin
Herbal menthol leaf
Herbal buchu water
Allium sativum (L.)
Glycyrrhiza glabra (L.)
Daucus carota (L.)
Hypoxis argentea (Fiscand)
Strychnos decussata (Pappe) Gilg
Gunnera perpensa (L.)
Mentha piperita (L.)
Agathosma betulina (Berg)
Rhizome
Root
Root
corms
Bark
Rhizome
Leaf
Leaf
EL Inongwe
Intelezi
Ngcambumvuthuza
Inqwebeba
Iqwili
Hypoxis argentea (Fiscand)
Haworthia reinwardtii (Haw)
Ranunculus multifidus (Forssk)
Albuca flaccid (Jacq.)
Alepidea amatymbica (Eckl. & Zeyh.)
corms
Leaf
Root
Leaf
Rhizome
FB Buchu leaf
Mountain garlic
Ginger
Chilli pepper
Agathosma betulina (Berg)
Allium sativum (L.)
Zingiber officinalis (L.)
Capsicum annuum (L.)
Leaf
Rhizome
Rhizome
Fruit
KWTa Maphipha
Mnonono
Ixonya
Inongwe
Sicimamlilo
Iphuzi
Rapanea melanophloeos (L.)
Strychnos decussate (Pappe) Gilg
Kniphofia drepanophylla (Baker)
Hypoxis argentea (Fiscand)
Pentanisia prunelloides (Klotzsch)
Centella eriantha (Rich.)
Bark
Bark
Root
Corms
Rhizome
Rhizome
KWTb Umdlavuza
Mnonono
Inceba emhlophe
Lauridiatetragonia (L.F.) Strychnos
decussate (Pappe) Gilg
Hermannia sp. (L.)
Root
Bark
Root
KWTc Mnonono Strychnos decussate (Pappe) Gilg Bark
HBfs Red carrot
Mlungu mabele
Calmoes
Mountain garlic
Daucus carota (L.)
Zanthoxylum capense (Thunb.)
Acorus calamus (L.)
Allium sativum (L.)
Root
Bark
Rhizome
Rhizome
HBss Buchu leaf
Chilli pepper
Agathosma betulina (Berg)
Capsicum annuum (L.)
Leaf
Vegetable
HBts Maphipha
Red carrot
Uroselina
Mountain garlic
Rapanea melanophloeos (L) Mez
Daucus carota (L.)
Cinnamomum camphora (L.) J. Presl
Allium sativum (L.)
Bark
Root crop
Bark
Rhizome
Name/code Local name Botanical name Parts used
AL Mountain garlic
Mlomo mnandi
Red carrot
Inongwe
Mnonono
River pumpkin
Herbal menthol leaf
Herbal buchu water
Allium sativum (L.)
Glycyrrhiza glabra (L.)
Daucus carota (L.)
Hypoxis argentea (Fiscand)
Strychnos decussata (Pappe) Gilg
Gunnera perpens (L.)
Mentha piperita (L.)
Agathosma betulina (Berg)
Rhizome
Root
Root
corms
Bark
Rhizome
Leaf
Leaf
EL Inongwe
Intelezi
Ngcambumvuthuza
Inqwebeba
Iqwili
Hypoxis argentea (Fiscand)
Haworthia reinw rdtii (Haw)
Ranunculus multifidus (Forssk)
Albuca flaccid (Jacq.)
Alepidea amatymbica (Eckl. & Zeyh.)
corms
Leaf
Root
Leaf
Rhizome
FB Buchu leaf
Mountain garlic
Ginger
Chilli pepper
Agathosma betulina (Berg)
Allium sativum (L.)
Zingiber officinalis (L.)
Capsicum annuum (L.)
Leaf
Rhizome
Rhizome
Fruit
KWTa Maphipha
Mnonono
Ixonya
Inongwe
Sicimamlilo
Iphuzi
Rapanea melanophloeos (L.)
Strychnos decussate (Pappe) Gilg
Kniphofia drepanophylla (Baker)
Hypoxis arge tea (Fiscand)
Pentanisi pr nelloides (Klotzsch)
Centella eriantha (Rich.)
Bark
Bark
Root
Corms
Rhizome
Rhizome
KWTb Umdlavuza
Mnonono
Inceba emhlophe
Lauridiatetragonia (L.F.)
Strychnos decussate (Pappe) Gilg
Hermannia sp. (L.)
Root
Bark
Root
Name/code Local name Botanical name Parts used
KWTc Mnonono Strychnos decussate (Pappe) Gilg Bark
HBfs Red carrot
Mlungu mabele
Calmoes
Mountain garlic
Daucus carota (L.)
Zanthoxylum capense (Thunb.)
Acorus calamus (L.)
Allium sativum ( .)
Root
Bark
Rhizome
Rhizome
HBss Buchu leaf
Chilli pepper
Agathosma betulina (Berg)
Capsicum annuum (L.)
Leaf
Vegetable
HBts Maphipha
Red carrot
Uroselina
Mountain garlic
Rapanea melanophloeos (L) Mez
Daucus carota (L.)
Cinnamomum camphora (L.) J. Presl
Allium sativum (L.)
Bark
Root crop
Bark
Rhizome
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Sample preparation
The already prepared water remedies were put in 2-li-
ter containers. Each remedy was filtered with a Buchner 
funnel and Whatman No. 1 filter paper. The filtrate ob-
tained was frozen at -40°C and freeze dried for 48h using 
a freeze dryer (Vir–Tis benchtop K, Vir–Tis Co., Gar-
diner, NY). The resulting sample was dissolved in 100% 
dimethylsulfoxide (DMSO) to a concentration of  50 mg/
ml to make a stock solution45.
Microbial strain and medium used for the assays
Reference MTB strain H37Rv (ATCC 25618) was used 
for the anti-Mycobacterium tuberculosis assay. It was obtained 
from American Type, MD, USA Culture Collection. Bac-
terial culture with DMSO (1.2%), isoniazid (INH) at 
MIC99 (0.05 µg/ml) and bacterial culture only were used 
as controls46.
Bacterial culture and drug preparation
Suspensions of  Mycobacterium tuberculosis H37Rv were 
grown using mycobacterial growth indicator tubes (MGIT). 
The inocula were prepared from Lowenstein–Jensen 
slants. To prepare an inoculum that was less than 15 days 
old from a culture grown on Lowenstein-Jensen medium, 
a suspension was prepared in saline and adjusted to a 1.0 
McFarland standard. The suspension was vortexed for 
several minutes and was allowed to stand for 20 min for 
the initial settling of  larger particles. The supernatant was 
transferred to an empty sterile tube and was allowed to 
stand for an additional 15 min. After being transferred to 
a new sterile tube, it was then adjusted to a 0.5 McFarland 
turbidity standard by visual comparison. A 1:5 dilution 
of  the bacterial suspension was prepared, and 0.5 ml was 
inoculated into MGIT 7H12® (MGIT 960 system, Bec-
ton Dickinson, Sparks, USA) tubes containing test and 
control compounds46.
The growth of  the organism was monitored through 
fluorescent changes due to oxygen consumption in the 
medium during active growth. Aliquots (100 µl) of each 
herbal medicine was added to the MGIT tubes contain-
ing bacteria in Middlebrook 7H12® media, with the fi-
nal DMSO concentration not exceeding 1.2%. The tubes 
were incubated at 37°C in MGIT system, and growth 
units (GU) were monitored for six days. All the remedies 
were tested at concentrations of 50 and 25 ug/ml46. 
For MIC99 evaluations, a 1% bacterial control culture 
was prepared in a drug-free MGIT tube and the MIC99 of 
the compound determined relative to the growth units of 
the control (GU–400). The MIC was determined as the 
lowest drug concentration that equals or lower than GU 
of the 1% bacterial culture. Controls that were also in-
cluded are bacterial culture with DMSO (1.2%), isoniazid 
(INH) and bacterial culture only. All the herbal prepara-
tions were tested at two-fold decreasing concentration46.
Results
In the present study, the susceptibility and minimum in-
hibitory concentration (MIC) of nine polyherbal medi-
cines were determined against M. tuberculosis H37Rv, in 
vitro. The susceptibility testing revealed that all the rem-
edies have anti-tubercular activity against M. tuberculosis 
H37Rv at concentrations below 50 µg/ml. Seven of these 
polyherbal preparations, namely; KWTa, KWTb, KWTc, 
HBfs, HBts, AL and FB showed activity at concentra-
tions below 25 µg/ml, with the remaining remedies show-
ing activity at concentrations between 25 and 50 µg/ml 
(Table 2).
All the remedies exhibited inhibitory activity against M. 
tuberculosis H37Rv with KWTa, HBfs and HBts as the 
most active remedies at 1.562 µg/ml, followed by AL 
remedy which showed growth inhibition at 3.125 µg/ml. 
The remaining preparations from KWTb, KWTc, HBss, 
EL and FB showed growth inhibition against M. tubercu-
losis at 25 µg/ml. However, isoniazid showed more inhib-
itory activity against M. tuberculosis H37Rv at 0.05 µg/ml 
when compared to the polyherbal remedies (Table 2).
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Table 2. Susceptibility testing and minimum inhibition concentration (MIC99) of nine 
polyherbal remedies against M. tuberculosis H37Rv using MGIT BACTEC 960 system 
Polyherbal 
remedies 
Susceptibility 
activity  (µg/ml) 
MIC99 of the remedies 
(µg/ml) 
KWTa < 25 < 1.562 
KWTb < 25 25 
KWTc < 25 25 
HBfs < 25 < 1.562 
HBss > 25 25 
HBts < 25 < 1.562 
AL < 25 3.125 
EL > 25 25 
FB < 25 25 
Isoniazid (INH) - 0.05 
Discussion
Tuberculosis has been a major health problem for devel-
oping countries including South Africa. The increasing 
resistance of  the disease to first and second line drugs has 
demanded the need for a new search for anti-mycobacteri-
al agents that could be effective, efficient, non-toxic and 
cost effective47.
The herbal preparations from KWTa, HBfs, HBts and 
AL showed a greater anti-mycobacterial activity, resulting in 
lower susceptibility patterns and MIC values observed. 
From observation, the aforementioned remedies contain 
a mixture of  two or more of  the following herbs: Allium 
sativum, Strychnos decussata, Daucus carota, Hypoxis argentea, 
Rapanea melanophloeo together with other herbs. Species of  
these plants have been investigated and shown to contain 
anthraquinones, glycosides, saponins, tannins, terpenoids, 
aloin, saponins, steroids and flavonoids48,49,50. Other 
compounds include alkaloids, terpenes, resin, monoter-
penoids, sesquiterpenoids and phenols which show activ-
ity against Mycobacterium tuberculosis51,15,52. Allium sativum is 
a plant that has been reported as an established remedy 
for the treatment of  tuberculosis53. It possesses variety 
of  biological properties such as anti-cancer, anti-micro-
bial, antioxidant, immunomodulatory, anti-inflammatory, 
hypoglycaemic and anti-cardiovascular properties54. Sev-
eral studies conducted on the in vitro activity of  Allium 
sativum against Mycobacterium tuberculosis revealed that this 
plant possesses anti-tubercular properties41,42,53,53. The 
presence of  sulphur compounds such as allicin, ajoene, 
allylmethyltrisulfide, diallyltrisulfide, diallyldisulphide has 
been associated with the anti-tubercular activity of  this 
Allium sativum55.
Information on the use of  Strychnos decussate as an anti-tu-
bercular agent has not been reported. This study is the 
first to report the use of  this plant as a remedy for the 
treatment of  TB. However, it has been reported to pos-
sess anti-fungal activity56. Daucus carota is a root vegetable. 
There are only a few reports on the anti-tubercular activ-
ity of  this plant57,58. However, it has been reported to be 
used as an anti-bacterial59, anti-fertility60, anti-oxidant61, 
ophthalmic and stimulant62, anti-septic, diuretic, hepato-
protective, anti-inflammatory63,64, anti-helmintic, carmi-
native65, deobstruent, diuretic and galactogogue. Accord-
ing to the reports, phenolics, polyacetylenes, carotenoids, 
ascorbic acid and tocopherol are the most abundant phy-
tonutrients present in this plant66. Hypoxis argentea has also 
been reported to be used as a remedy for the treatment 
of  TB58. Species of  the genus Hypoxis have been used as 
anti-bacterial, anti-fungal, anti-viral, anti-oxidant, anti-in-
flammatory, anti-diabetic, cardiovascular, anti-convulsant 
and anti-cancer67,68,69,70,71. The presence of  several com-
pounds, especially glucosides, sterols and sterolins could 
be responsible for the different activities found in Hy-
poxis72. Rapanea melanophloeo has been screened for activity 
and found active against drug-resistant and drug-sensitive 
strains of  Mycobacterium tuberculosis73,74. This plant has been 
reported to contain bioactive compounds such as ben-
zoquinones, saponins and tannins which could probably 
contribute to its activity73.
The high activity of  these polyherbal remedies against M. 
tuberculosis could be attributed to the presence of  multiple 
active constituents which may act in synergy and produce 
greater anti-mycobacterial activity. This is an indication that 
many natural products are potential source of  antimyco-
bacterial agents42.
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Conclusion
This study has revealed that polyherbal remedies have the 
potential to cure tuberculosis. This is the first research 
work on the anti-tuberculosis activity of  polyherbal medi-
cines used for the treatment of  tuberculosis in South Af-
rica. The remedies might be potential sources of  new an-
ti-mycobacterial agents as they all showed activity against 
M. tuberculosis. However, the activity of  these remedies
and their active principles still require in vivo study in or-
der to validate their potential as anti-tuberculosis agents.
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ABSTRACT
Background: In many immunocompromised patients, opportunistic 
bacterial and fungal infections are common. Polyherbal medicines examined 
in this study are used by the indigenous people of South Africa for the 
treatment of tuberculosis (TB) and other opportunistic infections associated 
with TB. Objective: To evaluate the antibacterial and antifungal activity of 
nine polyherbal remedies against four Gram-positive and Gram-negative 
bacteria respectively and three fungi. Materials and Methods: Agar dilution 
method was used to determine the minimum inhibitory concentration 
(MIC) of the remedies against the organisms. Results: The inhibitory 
activity of the polyherbal medicines based on the overall MIC revealed that 
HBfs and FB remedies were the most active remedies against the bacterial 
isolates at the concentration of 2.5 mg/mL, followed by HBts remedy at 5.0 
mg/mL. However, the MIC valves of KWTa, KWTb, KWTc, HBss, EL and AL 
remedies were higher than 5.0 mg/mL which was the highest concentration 
used. Only KWTa remedy showed activity against Aspergillus niger and 
Aspergillus fumigatus with the MIC value of 2.5 mg/mL. While KWTc and 
HBts had the highest activity at 1.25 mg/mL against Candida albicans, the 
remaining remedies were active at 2.5 mg/mL. Conclusion: This study 
revealed that some of these polyherbal formulations have activities against 
some of the opportunistic bacterial and fungal isolates associated with TB 
patients. The capability of these remedies to inhibit the organisms is an 
indication that they are a potential broad-spectrum antimicrobial agent. 
However, the remedies that are inactive might contain stimulant effects 
on the immune system.
Key words: Antibacterial, antifungal, polyherbal medicines, tuberculosis
SUMMARY
• In the Eastern Cape Province of South Africa, no study has been reported
on the effect of polyherbal remedies used for the treatment of TB on 
the opportunistic pathogen. This study therefore revealed that some of 
the polyherbal medicines possess activity against bacterial and fungal 
pathogens.
Abbreviations used: TB: Tuberculosis; MIC: Minimum Inhibitory 
Concentration; CFU/ML: Colony Forming  
Unit Per Mill.
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antibiotics not only leave the patients with impaired immunity but 
also predispose them to opportunistic pathogens.[11,12] The suppression 
of human defense mechanism during the course of active TB makes 
the patients vulnerable to pathogenic and opportunistic pathogens, 
and, as such, acquires fungal infection in addition to bacterial, viral 
and parasitic infections.[13,14] These organisms invade any part of 
the body and cause secondary infections.[15] In addition, with the 
increasing incidence of resistant strains of bacteria and fungi with 
commonly used anti-infective agents and the persistence of these 
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INTRODUCTION
The u se o f h erbal m edicines f or t he p revention a nd c ure o f v arious 
diseases has increased tremendously all over the world in the recent 
years. They are believed to be safe, effective, accessible, and free from 
serious adverse reactions.[1,2] These medicines are often “p olyherbal” 
preparations made from the mixtures of various medicinal plants. 
Hence, they contain multiple bioactive constituents that interact 
with each other in the formulation and achieve extra therapeutic 
effectiveness.[3] Due to the wide therapeutic range and high efficiency 
of polyherbal formulations, they are used for the treatment of 
a vast number of diseases such as diabetics, arthritis, liver and 
kidney disorders, cough, asthma, fever, respiratory disorders, and 
tuberculosis (TB).[4-9]
TB is a chronic infectious disease and has remained one of the 
major public health problems in South Africa. The country ranks the 
third highest in the world with a high incidence of TB with about 
80% of the population infected with latent TB.[10] The chronic nature 
of tubercular infection coupled with long-term administration of 
© 2017 Pharmacognosy Magazine | Published by Wolters Kluwer - Medknow 
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organisms in immunocompromised patients, it is of great importance 
to find effective antimicrobial agents against the infections caused by 
these organisms.
The most common opportunistic bacterial infections in 
immunocompromised TB patients are members of the family 
Enterobacteriaceae, Pseudomonas spp. and Staphylococcus spp.[14] 
These bacteria have been extensively studied and found to cause 
infections in patients undergoing prolonged use of antibiotics and 
immunosuppressed individual.[14,16,17] The synergistic growth promoting 
association of fungi and Mycobacterium has been reported in pulmonary 
TB patients.[18] This is due to the prolonged use of chemotherapy with or 
without corticosteroids which promotes the growth and reproduction of 
opportunistic fungi and, in turn, aggravates the course of the underlying 
process in the lung tissues.[19] The major opportunistic fungal pathogens 
that have been reported to cause infections in TB patients include 
Aspergillus spp. causing aspergillosis, Candida spp. causing candidiasis, 
Cryptococcus neoformans causing cryptococcosis, and Mucor spp. 
causing mucormycosis.[12,18,20] Several researchers have investigated 
the antibacterial and antifungal activity of medicinal plants used for 
the treatment of TB in the province.[21,22] However, no study has been 
reported on the antimicrobial effect of polyherbal remedies used for the 
treatment of TB. Since opportunistic bacterial and fungal pathogens 
tend to cause diseases in TB patients, the study was, therefore, aimed at 
evaluating the antimicrobial effect of polyherbal medicines used for the 
treatment of TB in the Eastern Cape Province of South Africa, in other to 
determine whether they could also serve as antibacterial and antifungal 
agents.
MATERIALS AND METHODS
Sample collection
Polyherbal medicines evaluated in this study were purchased from herbal 
healers in five communities, namely, Alice  (AL), East London  (EL), 
Fort Beaufort  (FB), Hogsback, and King Williams Town. These are 
some of the towns within the Amathole District Municipality of 
Eastern Cape Province, South Africa. Each of the aqueous formulation 
was already prepared and packaged into a clean 2-L container by the 
herbal healers. The remedies were called TB healing remedy. Thus, 
they were code-named according to their respective place of collection 
as follows; King Williams Town site A  (KWTa), King Williams Town 
site B  (KWTb), King Williams Town site C  (KWTc), Hogsback first 
site (HBfs), Hogsback second site (HBss), Hogsback third site (HBts), 
EL, AL, and FB. The samples were transported to the laboratory for 
analysis.
Sample preparation
All the polyherbal preparations were filtered using Buchner funnel and 
Whatman No. 1 filter paper. The filtrate obtained was frozen at − 40°C 
and freeze-dried for 48  h using a freeze-dryer  (VirTis BenchTop K, 
VirTis Co., Gardiner, NY, USA). Each of the samples was re-suspended 
in distilled water to yield 100 mg/mL stock solution.[23]
Microorganisms and media
The bacteria and fungi used in this study were chosen primarily on the basis 
of their importance as opportunistic pathogens of humans infected with 
TB.[12,22,24] Strains from the American Type Culture Collection (ATCC) 
were used for both assays. The bacteria used include four Gram-positive 
and Gram-negative bacteria, namely, Staphylococcus  aureus ATCC 
29213, Bacillus cereus ATCC 10702, Enterococcus faecalis ATCC 29212, 
Streptococcus pyogenes, Pseudomonas aeruginosa ATCC 27853, Klebsiella 
pneumoniae ATCC 100031, Escherichia coli ATCC 8739, and Salmonella 
typhimurium ATCC 13311.
For the antifungal analysis, the fungal strains used include Candida 
albicans ATCC 10231, Aspergillus fumigatus ATCC 204305, and 
Aspergillus niger ATCC 16888. Mueller-Hinton Agar  (MHA), Mueller 
Hinton Broth (MHB), Sabouraud Dextrose Broth (SDB), and Sabouraud 
Dextrose Agar  (SDA) used were obtained from BioLab and were 
prepared according to the manufacturer’s instructions.
Preparation of inocula
For the bacterial inoculum preparation, all the test bacteria strains that 
were maintained on nutrient agar slants were recovered in sterile MHB 
and incubated overnight at 37°C. In other to obtain distinct colonies, 
the 24 h old cultures were diluted 1:100 v/v in fresh sterile MHB and 
cultured on MHA overnight at 37°C. The colony suspension method 
of EUCAST[25] was used for the preparation of the inoculum. Identical 
colonies from the culture were suspended in 0.85% sterile saline, 
adjusted with saline and compared with 0.5 McFarland standards to 
obtain a suspension density equivalent to 106 CFU/mL. The suspensions 
were confirmed by spectrophotometric reading at 600  nm. The cell 
suspensions were finally diluted 1:100 by transferring 0.1  mL of the 
bacterial suspension into 9.9 mL of sterile broth to give an approximate 
inoculum of 104 CFU/spot.[26] The inocula suspensions were used for 
inoculation within 15 min.
For the fungal inoculum preparation, modified method of Therese et al.[27] 
was used for the analysis. The fungi strains were freshly sub-cultured on 
SDA and incubated at 25°C for 72 h. About 1 cm2 of 3-day-old spore 
producing cultures were dropped in sterile distilled water and vortexed 
for 30 s to release the fungal spores. The spore density of each fungus 
was adjusted with a spectrophotometer at 580  nm to obtain a final 
concentration of approximately 105 spores/mL. Cell suspensions were 
finally diluted to 104 CFU/spot.[28] For the Candida spp., the inocula were 
prepared by adding 1.0 mL of overnight Candida cultures to 9.0 mL of 
SDB to yield 104 CFU/spot of the inoculum.[29]
Antibacterial and antifungal minimum inhibitory 
concentration assays
Determination of the minimum inhibitory concentration of the 
herbal remedies against bacterial isolates
The antibacterial activity of the polyherbal remedies was carried out 
using the agar dilution method of Afolayan and Meyer[30] with slight 
modification. MHA was prepared according to the manufacturer’s 
instructions and placed in a water bath at 50°C to prevent solidification. 
From the stock solution of each remedy  (100  mg/mL), different 
concentrations of 5.0, 2.5, 1.25, 0.625, 0.3125, and 0.15625 mg/mL were 
prepared and incorporated in the molten agar  (three replicates). The 
agar containing the remedy was poured into sterile Petri dishes, swirled 
carefully and allowed to cool. The controls used were blank plates 
containing only MHA, another plates containing MHA and 1.0 mL of 
distilled water which is the solvent of extraction (negative control), and 
plates containing 0.0125–0.000391 mg/mL of ciprofloxacin serves as the 
positive controls. Ten microliters of the standardized bacterial cultures 
were streaked in a radial pattern on the solidified agar remedy plates. 
The plates were incubated at 37°C for 24–72  h. The concentration at 
which there was no visible growth of the organism on the agar plates 
was considered the minimum inhibitory concentration  (MIC) of the 
remedy.[25]
Determination of the minimum inhibitory concentration of the 
herbal remedies against fungal isolates
The antifungal activity of the remedies was evaluated using the agar 
dilution method of Therese et  al.[27] with slight modification. SDA 
was prepared according to the manufacturer’s instructions and placed 
91
ELIZABETH BOSEDE FAMEWO, et al.: Antimicrobial Activity of Polyherbal Medicines
Pharmacognosy Magazine, Volume 13, Issue 51, July-September 2017 (Supplement 3) S541
in a water bath at 50°C to prevent solidification. Before congealing, 
different volumes of the herbal remedies were added to the SDA 
to have concentrations ranging between 0.15625 and 5.0  mg/mL. 
The controls used were blank plates containing only SDA, another 
containing SDA and 1.0 mL of distilled water (negative control), and 
plates containing 12.5–0.391  µg/mL of amphotericin-B  (positive 
controls). Ten microliters of the final suspensions were placed on 
the solidified agar remedy plates. The plates were incubated at 28°C 
for 48–96 h. The concentration at which there was no visible growth 
of the organism on the agar plates was considered the MIC of the 
remedy.[27]
RESULTS
Effect of the herbal remedies on bacterial isolates
Evaluation of the antibacterial activity of the nine polyherbal remedies 
against eight bacterial isolates revealed that three of the herbal 
formulations, namely, HBfs, FB, and HBts exhibited antibacterial 
properties  [Table  1]. The growth of K.  pneumoniae, P.  aeruginosa, 
E. coli, E.  faecalis, B.  cereus, and S.  aureus was inhibited by HBfs
remedy at a concentration of 2.5 mg/mL while Salmonella typhimurium
and Streptococcus pyogenes were inhibited at the MIC of 5.0  mg/mL.
Furthermore, FB preparation was active against six bacteria, namely,
P. aeruginosa, S.  typhimurium, E.  faecalis, S.  pyogenes, B.  cereus,
and S.  aureus at the MIC of 2.5  mg/mL, while K.  pneumoniae and
E. coli were inhibited at 5.0  mg/mL. HBts remedy showed activity
at 5.0  mg/mL against eight isolates except on B.  cereus which was
resistant to the remedy. The MIC of KWTa, KWTb, KWTc, HBss, EL,
and AL remedies against the bacterial isolates was higher than 5 mg/
mL which was the highest concentration used. However, the standard
antibiotic (ciprofloxacin) used as a positive control inhibited the isolates 
at the concentration of 0.0015625  mg/mL except on S.  typhimurium
were the MIC at 0.003125 mg/mL [Table 1]. The inhibitory activity of
the herbal formulations based on the overall MIC revealed that HBfs
and FB remedies were the most active against the bacterial isolates
followed by HBts, while the remaining formulations showed no activity
at the concentration used [Table 1].
Effect of the herbal remedies on fungal isolates
The effects of the remedies against the fungal isolates are shown in Table 2. 
Among the nine herbal formulations tested, only KWTa remedy was 
active against A. niger and A. fumigatus with the MIC value of 2.5 mg/mL 
[Table  2]. Other remedies; KWTb, KWTc, HBfs, HBss, HBts, AL, EL, 
and FB were inactive against Aspergillus spp. at the concentration used in 
this study. However, all the remedies showed activity against C. albicans. 
The highest activity was recorded in KWTc and HBtt remedies with the 
MIC value of 1.25 mg/mL while the remaining remedies had the MIC of 
2.5 mg/mL. The activity of these remedies against the yeast (C. albicans) 
alone suggest that the remedies might not have high efficacy with a broad 
spectrum of antifungal activity compared to the drug (amphotericin B) 
used as a positive control which inhibited the isolates at the concentration 
of 0.391 µg/mL [Table 2].
DISCUSSION
Polyherbal formulations are well known used Ayurvedic medicines 
for their effectiveness against a wide range of diseases.[31] They contain 
multiple bioactive constituents that act synergistically and achieve extra 
therapeutic effectiveness. Polyherbal formulations have been reported 
to possess activity against opportunistic antibacterial and antifungal 
isolates.[32-36] However, herbal formulations examined in this study are 
used by TB-patients for the treatment and management of TB, especially, 
in the Eastern Cape Province, South Africa. Ta
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In this study, three of the herbal formulations exhibited antibacterial 
properties against both Gram-negative  (P.  aeruginosa, K.  pneumoniae, 
E. coli, and S.  typhimurium) and Gram-positive bacteria  (E.  faecalis,
S. pyogenes, B. cereus, and S. aureus). This is an indication that the herbal 
preparations possess good antibacterial activity against the opportunistic 
bacteria capable of causing infection in TB-patients when compared
with other remedies. From the results, the response of the bacteria to the 
remedies varied among the isolates and the concentrations. The variation 
in the MIC of the polyherbal remedies could be due to the mode of action, 
the differences in cell wall composition and/or genetic content of the
organisms[37] as well as the synergistic effects of different phytochemicals 
present in the herbal formulations. The antibacterial activity of HBfs,
FB, and HBts remedies at relatively minimal concentrations could
be attributed to the bioactive constituents present in the remedies at
different concentrations, its ability to damage the cell walls to allow the
active compounds to absorb, diffuse, penetrate and interact with the
target sites and potent enough to inhibit, or kill microbial agents.[38]
Furthermore, the results showed that all the remedies were active against 
the growth of only the yeast (C. albicans). The resistance of Aspergillus 
spp. suggests that the remedies might not have high efficacy with a broad 
spectrum of antifungal activity when compared with amphotericin-B 
which showed activity against the three fungi. However, the activity of 
KWTa remedy could be attributed to the presence of bioactive antifungal 
agents which are not in the other remedies. In general, the poor growth 
inhibitory activity against some of the organisms demonstrated by some 
of these remedies could be attributed to the solvent (water) used by the 
herbal healers for their preparation. Aqueous extracts have been reported 
to be generally less active as described in many previous studies.[37,39,40] The 
activity of these remedies on the opportunistic pathogens does not mean 
that they are inactive. They may act by stimulating the immune system 
of the patient, or by creating internal conditions that are unfavorable for 
the multiplication of the microorganism.[21]
CONCLUSION
This study revealed that some of these polyherbal formulations have 
activities against some of the opportunistic bacterial and fungal isolates 
associated with TB patients. The capability of these remedies to inhibit 
the organisms is an indication that they are a potential broad-spectrum 
antimicrobial agent. However, the remedies that are inactive might 
contain stimulant effects on the immune system.
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Abstract
Background: Polyherbal remedies are widely used for the treatment and management of various diseases in developing countries. These
remedies often contain active pharmacological compounds, thus, the evaluation of herbal remedies used for the treatment of tuberculosis
in the Eastern Cape province for their toxicity is of great importance. Materials and Methods: Nine polyherbal medicines used for the
treatment of tuberculosis were assayed for their toxicity using hatchability success and larval mortality of brine shrimp (Artemia salina
Leach). These remedies were liquid preparations  and  coded  according  to  their respective  place  of  collection,   viz.,  King Williams Town
site A, King Williams Town site B, King Williams Town site C, Hogsback first site, Hogsback second site, Hogsback third site, East London,
Alice and Fort Beaufort. Results: The percentage hatchability success of 44.42, 42.96 and 39.70% were observed in cysts incubated with
herbal preparations from King Williams Town site A, Hogsback first site and Hogsback third site, respectively. The hatching success in these
remedies was significantly higher than the positive control (nystatin) and the negative control (sea water) at p<0.05. The herbal
preparations from King Williams Town site A and East London exhibited significantly more inhibitory hatchability effects with minimum
inhibitory concentration values of 2.4 and 2.8 mg mLG1, respectively. The mortality of A. salina nauplii  incubated in Alice, King Williams
Town site  B  and  King  Williams  Town  site  C  remedies  was  significantly  higher  than  when  larvae  was  incubated  in both controls.
Based on Meyer’s index, the LD50 of each polyherbal medicine was between 2.9-4.0 mg mLG1, the LD50 values greater than 1 mg mLG1.
Conclusion: The polyherbal remedies evaluated in this study are considered non-toxic and are therefore safe for the patients. However,
further  in  vivo  toxicity tests are required to validate the safe use of these polyherbal remedies.
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INTRODUCTION
Polyherbal medicines are extensively used in many
developing countries for the prevention and treatment of
various diseases such as diabetics, wound infection and 
tuberculosis. These preparations are freely hawked in South
Africa and are prevalent in other African societies. They are
readily available and affordable. Polyherbal preparations
contain a mixture of three or more medicinal plants. The
rationale behind the combination of these herbs could not be
justified by the traditional healers as it was a practise that they
found to be effective. A review of studies into medicinal plants
used to treat various diseases revealed that 80% of the people
in South Africa make use of herbal remedies for the treatment
of ailments at some stage in their life1.
Despite the widespread use of polyherbal remedies for
the treatment of several illnesses, little is known about their
toxicity and safety. The evaluation of the toxic action of these
remedies is important in order to acquire their maximum
benefits to humans,  even  though  they  have  been proven to
be efficacious in pharmacological studies or by clinical
evaluation2. The reports of patients experiencing adverse
effects such as diarrhoea, abdominal pain, ulcer, dizziness, loss
of appetite, abortion of pregnancy and stroke caused by these
remedies are on the rise3. Other dangerous effects include
heart attacks, heart-rate irregularities, liver toxicity, seizures,
psychoses and death4,5. Hence, the need to analyse the
physiological effects of polyherbal remedies is imperative.
This toxicity test aims at establishing the therapeutic
index, LD50. The greater the index the safer the remedies, the
smaller this margin the more chances of producing unwanted
effects6. In the literature, there is no information on the
toxicological study of polyherbal medicines in South Africa to
authenticate their usage and guarantee the safety of the users.
Thus, the objective of the current study was designed to
investigate the toxicity of polyherbal medicines used for the
treatment of tuberculosis in the Eastern Cape province using
brine shrimp assay.
MATERIALS AND METHODS
Collection of polyherbal medicines: Polyherbal medicines
evaluated in this study were purchased from hawkers and
healers in five communities namely, Alice, Fort Beaufort,
Hogsback, King Williams Town and East London, all within the
Amathole district municipality of the Eastern Cape province,
South Africa. Each of the liquid remedy was already prepared
by the seller and packaged in a 2 L container. They were
transported to Medicinal Plants and Economic Development
Research Centre, University of Fort Hare for analysis. Each
medicine was labelled and coded according to their respective
place of collection; namely: King Williams Town site A (KWTa),
King Williams Town site B (KWTb), King Williams Town site C
(KWTc), Hogsback first site (HBfs), Hogsback second site (HBss),
Hogsback third site (HBts), East London (EL), Alice (AL) and
Fort Beaufort (FB).
Sample preparation: Each remedy was filtered using Buchner
funnel and Whatman No. 1 filter paper. The filtrate obtained
was frozen at -40EC and freeze dried for 48 h using a freeze
dryer (Vir Tis benchtop K, Vir Tis Co., Gardiner, NY). The
resulting sample was packaged in a clean container. For brine
shrimps experiment, each sample was re-suspended in sea
water to yield a 20 mg mLG1 stock solution.
Assay procedure: The assay was carried out using modified
method of Otang et al.7. Five petri dishes containing 30 mL of
filtered sea water each was prepared and a two-fold dilution
was set up to yield a series of concentrations (1, 0.5, 0.25, 0.125
and 0.0625 mg mLG1) of the polyherbal medicines. A positive
control was prepared in test tubes containing nystatin in
seawater (30 µL mLG1), while petri dishes containing sea water
only served as the blank control.
Brine shrimp (Artemia salina) hatchability assay: The
Artemia salina cysts (Sera, Heidelberg, Germany) were
obtained    from    an    aquaculture    shop    in    East    London,
South Africa. These were used to evaluate the hatchability
success of A. salina cysts against different concentrations of
the polyherbal  medicines8.  Briefly,  different concentrations
(0.0625-1 mg mLG1) of the herbal remedies and positive
control were prepared in sea water. The A. salina cysts were
stocked at a density of 15 individuals per petri dish containing
30 mL of the incubation medium at varying concentrations.
The plates were partly covered and incubated at 28EC under
constant illumination in a digital incubator (MRC Laboratory
equipment, model LE-509) and aeration. Thereafter, the petri
dishes were examined with the aid of a hand lens against a
white background that allowed the nauplii to be separated
from the shells. The number of free nauplii in each petri dish
was counted after every 12 h for 72 h. The percentage of
hatchability success was calculated by comparing the number
of hatched nauplii in a chosen concentration with the total
number of cysts stocked9. The minimum concentration of the
polyherbal medicines (or control drug) that inhibited the
hatching of the cysts was taken as the MIC. All the assays were
carried out in three replicates.
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Brine shrimp lethality assay: This was carried out in order to
determine the toxic level of the polyherbal preparations.
About 1 g of the shrimp cysts were introduced into 1 L sea
water. The beaker was partly covered and incubated at 28EC
under constant illumination in a digital incubator and
aeration. After 36 h of hatching, the phototropic nauplii were
collected and an aliquot (0.15 mL) containing 15 nauplii was
pipette into each petri dish for each remedy solution and
controls. The numbers of surviving larvae in each petri dish
were counted after every 12 h. The setup was allowed to
remain for 72 h under constant illumination. Finally, the
percentage of deaths was calculated. Larvae were considered
dead if they did not exhibit any internal or external movement
during several seconds of observation9.
The percentage of mortality was calculated as follows:
(Total nauplii-Alive nauplii)Mortality (%) = ×100%
Total nauplii
Determination of MIC 50 and LD50: The percentage
hatchability success and mortality data obtained from the five
concentrations of each polyherbal remedy was used to
construct a dose-response curve. The Minimum Inhibitory
Concentration (MIC 50) was determined as the concentration
of the polyherbal remedy/control drug that inhibited hatching
of 50% of the cysts. The LD50 was taken as the concentration
required for producing 50% mortality10. The LD50 values were
determined from the best-fit line obtained by linear regression
analysis of the percentage lethality versus the concentration.
Statistical analysis: Statistical analysis was performed on 
MINITAB version 12 for windows (Minitab Inc., Pennsyvania, 
USA). One-way analysis of variance was used to test for the 
effect of concentration and time of exposure of the herbal 
remedies on the hatchability success of the cysts and mortality 
of the larvae in comparison to controls11. The study samples 
were tested for normality. The p-value less than 0.05 were 
considered significantly different.  
RESULTS AND DISCUSSION
Brine shrimp hatchability assay: The percentage hatchability 
success of Artemia salina  cysts incubated with different 
polyherbal medicines are shown in Fig. 7.1. High 
hatchability successes of 44.42, 42.96 and 39.70% were 
observed in the cysts incubated with polyherbal remedies 
from KWTa, HBfs and HBts, respectively and were 
significantly higher than the controls. On the other hand, 
the hatching success of brine shrimps in KWTc, HBss, FB and 
EL remedies were higher than those incubated in 
nystatin but lower than those in the sea water. 
The herbal preparations from AL and KWTb exhibited 
more inhibitory effects with hatchability successes of 
26.59 and 20.37%, respectively, which were lower than 
the controls. The inhibitory effects of the remedies on 
hatchability were expressed as MIC values (Table 7.1). 
The remedies from KWTa and EL exhibited more 
inhibitory hatchability effects with MIC values of 2.4 
and 2.8 mg mLG1, respectively. However, KWTb, FB and 
HBts preparations had the highest value of 3.9, 3.8 and 
3.9 mg mLG1, respectively, indicating that they could be 
less toxic among the 9 remedies (Table 7.1).
Fig. 7.1: Percentage hatchability success of A. salina cysts incubated in different polyherbal  medicines. Means are values of five
concentrations for each remedy ±SD. Bars with different letters are significantly different (p<0.05)
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Fig. 7.2: Percentage hatchability success of A.  salina  cysts  incubated  in different concentrations of polyherbal medicines. Bars
with different letters are significantly different
Table 7.1: Hatchability and lethality of A. salina incubated in different
concentrations of polyherbal medicines
Hatchability assay Lethality assay
-------------------------------------- ------------------------------------
Remedies MIC 50 (mg mLG1) R2 (%) LD50 (mg mLG1) R2 (%)
AL 3.0±0.87a 96 3.0±0.03a 99
KWTa 2.4±0.97b 88 3.1±0.00 b 97
KWTb 3.9±0.23c 74 3.8±0.68c 80
KWTc 3.5±0.99d 89 2.9±0.64d 91
HBfs 3.4±0.72e 88 3.4±0.15e 95
HBss 3.3±0.56f 96 3.2±0.04 f 96
HBts 3.8±0.83g 78 3.4±0.55g 92
FB 3.9±0.15h 74 3.7±0.00 b 84
EL 2.8±0.04i 93 4.0±0.01 h 70
Nystatin 3.3±0.68j 86 3.5±0.37i 92
Data are Means±SD of three replicates. Means with different superscript in the 
same column are significantly different (p<0.05), R2 (%) is the coefficient of 
determination of the regression equation
Effect of polyherbal medicines concentration on 
hatchability success: The hatchability success of A. salina 
cysts  decreased  significantly  with  increasing 
concentrations of the polyherbal medicines (Fig. 7.2). The 
herbal preparations from EL, HBfs, KWTa and HBts had the 
highest hatchability success  in  the  lowest  concentration.  
In  AL and  HBss remedies, the hatching success decreased 
with increase in concentrations of the treatments. However, 
the inhibition of the hatching success in FB preparation 
was significantly decreased at 1 mg mLG1. With increasing 
concentration from 0.0625 mg mLG1, the hatchability 
success of the cysts incubated with KWTb remedy elicited 
more inhibitory effect on the hatching success at 1 mg 
mLG1 (Fig. 7 . 2). Thus, the decrease  observed  in  the  
hatchability  success  of  A.  salina cysts as the concentrations 
increased could be as a result of the relative concentration of 
toxic metabolites present in the remedies  as  the  
concentration  increases.  However,  none of
the preparations exhibited total inhibition at 1 mg mLG1, this 
might be due to the cysts possessing a resistant cyst stage 
which makes it tolerant to wide range of salinities12.
Effect of exposure time on hatchability success: The effect of 
exposure time on hatchability obtained in this study revealed 
that the sensitivity of A. salina to polyherbal therapies was 
strongly dependent on exposure period (Fig. 7.3). The lowest 
hatchability success of the cysts was observed at 12 h of 
exposure in all the remedies. Higher hatchability success in 
incubations of KWTa, KWTc, HBfs, HBss, HBts and EL remedies 
at 24 h exposure were significantly higher than the controls. 
At 36 h of exposure, the hatchability successes of 49.78, 54 
and 51.11% was observed in KWTa, HBfs and HBts medicines, 
respectively. The hatching success of A. salina cysts into 
nauplii in incubations of AL, HBfs, HBss, HBts, FB and EL 
remedies at 48 h of exposure ranged from 39.56-59.56%. The 
optimal hatching of cysts to yield a large number of nauplii is 
achieved with 48 h of exposure13. In AL, KWTb and EL  
remedies, the hatchability success was lower when compared 
with both controls at 60 h of exposure. Likewise, the hatching 
success of all the remedies except KWTa was lower than in the 
sea water at 72 h of exposure. Artemia   is highly vulnerable to 
toxins and chemical metabolites at the early developmental 
stages14, this could have led to the very low hatchability 
success of the cysts observed at 12 h of exposure. Thus, the 
resistant cysts stage of A. salina to higher salinities makes the 
hatchability assay less desirable assay than the lethality test for 
the preliminary screening of herbal remedies’ toxicity test. The 
use of freshly hatched nauplii has been used to circumvent the 
toxic tolerant stage of A. salina cysts and this increases the 
sensitivity of the lethality assay11,7.
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Fig.  7.3: Percentage hatchability   success   of  A.  salina  cysts incubated at different durations in the polyherbal remedies. Bars with
different letters are significantly different
Fig.  7.4: Percentage mortality of A. salina nauplii incubated in different concentrations of the  polyherbal medicines. Bars marked
with different letters are significantly different
Effect  of    varying    concentrations    on   brine shrimp  
mortality: The effect  of  varying  concentrations of polyherbal 
remedies on the mortality of larvae is shown in Fig. 7.4. 
The degree of mortality of nauplii in all the remedies 
was in concentration  dependent  fashion.   The  percentage 
mortality of larvae in HBfs, HBss, HBts, EL and FB 
remedies was significantly lower than the positive 
control. Maximum mortalities of  94.63,  78.72  and  94.67%  
occurred  at the highest concentrations of 1 mg mLG1 in  
incubations of AL,  KWTb  and   KWTc, respectively,  which  
was  significantly  higher than  the  positive  control.  It  
could  be  deduced that the polyherbal remedies have 
both toxicological and pharmacological  activities  
based  on  the  dosage administered.
Effect of exposure time on brine shrimp mortality: The effect 
of remedies on the larvae over a period of time was carried out 
to determine the sensitivity of the larvae to toxic secondary 
metabolites present in the remedies. The mortality of nauplii 
incubated in all the remedies increased exponentially with 
time  (Fig. 7. 5).  The  observed  result  was  depended  on  the 
length of incubation period as earlier reported by Otang et al .7. 
Exposure of the larvae for lesser periods (<36 h) in HBfs, HBss, 
HBts  and EL remedies did not induce mortality when  
compared with the controls. However, increase in mortality 
was observed in AL, KWTa, KWTb and KWTc remedies which 
was significantly higher than the controls, except at 72 h in 
nystatin. Brine shrimp nauplii attain the second and third 
instars of their life cycle within 48 h of exposure, thus revealed
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Fig.  7.6: Percentage mortality of A. salina nauplii incubated in different polyherbal medicines.  Means are values of 
five concentrations for each polyherbal remedy±SD. Bars  marked with different letters are significantly different
their greatest sensitivity to toxins at this time15. However,
these findings revealed that the maximum sensitivity of the
nauplii to the remedies was attained at 72 h of exposure. This
could probably be due to the presence of nutritive
metabolites in the remedies. Thus, the survival of high number
brine shrimp nauplii in all the remedies after 60 h of exposure
could be explained by the presence of non-toxic metabolites
in the polyherbal medicines.
Brine shrimp lethality assay: Brine shrimp lethality results
and LD50 values obtained are shown in Fig. 6 and Table 1,
respectively. The  larvae  mortality  of  A.  salina  nauplii 
incubated in AL, KWTb and KWTc remedies was significantly
higher  than   when   larvae  are  incubated  in  both  controls.
However,  lower larvae mortality was observed in the remedies 
from HBfs, HBss, HBts, FB and EL. Also, the number of larvae 
mortality was reduced in KWTa remedy than in nystatin but 
higher than those in sea water. While, EL remedy exhibited 
more lethality effects with LD value of 4.0, the lowest 
lethality effects was observed in KWTc remedy (Table 7.1).
In evaluating herbal preparations for toxicity, the LD50
values are commonly expressed either by comparison with 
Meyer’s or to Clarkson’s toxicity index. The extracts with LD50
less than 1000 µg mLG1 are considered as toxic, while extracts 
with LD50  greater  than  1000  µg  mLG1  are  considered as 
non-toxic13. Clarkson classified cytoxicity as non-toxic when 
LD50 is above 1000  µg  mLG1, low  toxic  when  the  LD50  is 
between 500 and 1000 µg mLG1, medium toxic when the LD50
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is between  100-500  µg  mLG1,  while  extracts  with   LD50  of
0-100 µg mLG1 are  highly  toxic16. According to these
benchmarks, the LD50 of the nine polyherbal medicines varied
between 3.0-4.0 mg mLG1, these estimated LD50 values are
greater than 1000 µg  mLG1  (Fig.  7.6,  Table  7.1).  Thus,  based 
on the  criterion  of  toxicity,  these   remedies   are
considered non-toxic.
CONCLUSION
The findings from this study have shown that polyherbal 
remedies used for the treatment of tuberculosis in the study 
area  exhibited  non-toxic  level  i.e.,  LD50  values  greater  than 
1 mg mLG1 with brine shrimp toxicity assays. Thus, they are 
considered safe for the patients. However, further in vivo 
toxicity test are required to validate the use of these 
polyherbal remedies.
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Evaluation of some important vitamins and mineral nutrients in polyherbal medicines 
used for the treatment of tuberculosis in the Eastern Cape Province, South Africa 
 
Abstract 
The aim of this study was to determine the nutritive properties of nine polyherbal 
formulations, used for the treatment of tuberculosis, in order to validate their ability in 
boosting the immune system of tuberculosis patients. The remedies were analysed for their 
nutritive properties using an inductively coupled plasma optical emission spectrometer. The 
vitamins A, E and C were also determined using standardized methods. The polyherbal 
preparations were found to be rich in vitamins and mineral nutrients. Calcium was the highest 
mineral nutrient detected, while the lowest nutrient was phosphorus. Quantitatively, calcium 
and magnesium contents in the remedies ranged from 973.30 to 6503.30 mg/100g and 80.00 
to 406.00 mg/100g respectively. The amount of phosphorus and potassium was between 20.00 
and 263.30 mg/100g; 160.00 and 2050.00 mg/100g respectively. Micro minerals such as iron, 
manganese, zinc, aluminium and copper were also detected. Iron was the highest nutrient in 
the majority of the polyherbal preparations while the lowest value was recorded for copper. 
However, vitamin C was absent in the herbal preparations while vitamin A and E were 
detected. Thus, these polyherbal formulations contain the essential vitamins and nutrients that 
are probably boosting the immune system of tuberculosis patients thereby aiding their 
recovery. 
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Introduction 
Tuberculosis (TB) is one of the deadliest diseases and has remained a major public health 
threat in most parts of the world (Chakraborty et al., 2014). Currently, it is estimated that over 
2 billion people are infected with TB, with 8.6 million new cases per year; leading to the death 
of 1.3 million, including 320,000 deaths of HIV-TB co-infected individuals (WHO, 2013a; 
Baldwin et al., 2015). In South Africa, about 80% of the population is infected with latent TB 
among the age group 30-39 years (TBFACTS, 2015). The disease is related to poverty, under-
nutrition and poor immune function (WHO, 2013b). TB and malnutrition constitute a 
substantial problem in the developing countries. Patients with active tuberculosis usually have 
low nutritional status, thus, suffer macronutrient and micronutrient malabsorption, reduction 
in appetite and altered metabolism of the body (Gupta et al., 2009). 
Vitamins and minerals are essential needed for normal growth and maintenance of body 
functions. The minerals (macro and micronutrients) work together for tissue regeneration, 
cellular integrity and play important roles in the treatment of tuberculosis (Gupta et al., 2009; 
WHO, 2013b). However, vitamins are bio-molecules that maintain the physiology of the body 
and boost the immune system. They are responsible for a spectrum of vital functions in the 
body due to their anti-oxidant, pro-oxidant, anti-inflammatory effects and metabolic functions. 
While vitamin A, C and E largely contribute to the anti-oxidant system of the human body 
(Ciccone et al., 2013; Wahlqvist, 2013; Chakraborty et al., 2014), vitamins C and E are 
effective in improving the immune responses to tuberculosis when given as an adjuvant to 
multidrug tuberculosis therapy (Safarian et al., 1989).  
The use of herbal medicines for the treatment of various illnesses in the developed and 
developing countries has increased tremendously over the past decade. These remedies 
contain multiple active constituents which act synergistically (Peltzer, 2009). They are 
believed to contain pharmacological properties capable of boosting the immunity of TB-
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infected individuals and aid quick recovery. The nutritive potential of a few polyherbal 
preparations have been investigated and found to be rich in mineral nutrients (Soni et al., 
2010; Dickson et al., 2014). However, the vitamins and mineral constituents of polyherbal 
remedies used for the treatment of tuberculosis in Eastern Cape Province have not been 
investigated. Thus, this research work was designed to evaluate some important vitamins and 
mineral elements in polyherbal medicines used for the treatment of tuberculosis in this region. 
 
Material and Methods 
Collection of polyherbal medicines  
Polyherbal medicines evaluated in this study were purchased from herbal healers in five 
communities namely; Alice, Fort Beaufort, Hogsback, King Williams Town and East London, 
all within the Amathole District Municipality, Eastern Cape Province, South Africa (Figure 
8.1). The remedies were already prepared and well packaged into clean containers by the 
herbal healers before being transported to the Medicinal Plants and Economic Development 
Research Centre, University of Fort Hare, Alice, for analysis. All the herbal preparations were 
air dried, ground to homogeneous powder and code-named according to their respective place 
of collection: viz; King Williams Town site A (KWTa), King Williams Town site B (KWTb), 
King Williams Town site C (KWTc), Hogsback first site (HBfs), Hogsback second site 
(HBss), Hogsback third site (HBts), East London (EL), Alice (AL) and Fort Beaufort (FB).  
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Figure 8.1: Map of Amathole District Municipality (Famewo et al., 2016) 
 
Determination of macro and micronutrients 
Digestion and analysis  
The method described by Bvenura and Afolayan (2012) was used for the digestion of the 
dried polyherbs. Selenium powder, sulphuric acid and salicylic acid were the reagents used for 
digestion. The finely ground material was divided into samples of 0.3 g, which were placed in 
dry and clean digestion tubes. A volume of 2.5 mL of the digestion mixture was added to each 
tube and allowed to react at room temperature for 120 min. The tubes were heated in a block 
digester at 110°C for 60 min. After removal from the digester, the tubes were allowed to cool 
and three successive portions of 1.0 mL hydrogen peroxide were added, allowing at least 10 
sec between additions because of the volatility of the reaction. The tubes were returned to the 
block digester at a temperature of 330°C and were removed from the block digester when the 
digest was colourless. The tubes were allowed to cool to room temperature before their 
contents were transferred to 50 mL volumetric flasks and deionized water was added to attain 
volumes of 50 mL. Standards were prepared for all the elements. The samples were then 
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analysed for the following nutrients: calcium, magnesium, sodium, potassium, nitrogen, 
phosphorus, iron, zinc, aluminium, manganese and copper using an inductively coupled 
plasma optical emission spectrometer (ICP OES; Varian 710–ES series, SMM Instruments, 
Cape Town, South Africa). All analyses were performed in triplicates. The macro and micro 
element contents were expressed as mg/100 g. 
 
Vitamin analysis 
Vitamin A content 
The vitamin A (Retinol) content of each herbal remedy was determined using the method of 
Onyesife et al. (2014).  A quantity, 1.0 g of ground sample was macerated with 20 mL of 
petroleum ether. This was decanted into a test tube and evaporated to dryness. About 0.2 mL 
of chloroform-acetic anhydride (1:1, v/v) was added to the residue. Two milliliters of TCA-
chloroform (1:1 v/v) was added to the resulting solution and absorbance was measured at 620 
nm using UV-3000PC spectrophotometer. Retinol standard was prepared in like manner and 
the absorbance was taken at 620 nm.  The concentrations of standard working solutions were 
10 μg/mL, 20 μg/mL, 40 μg/mL, 60 μg/mL, 80 μg/mL and 100 μg/mL respectively. The 
concentration of vitamin A in the sample was extrapolated from the standard curve using the 
equation: Y = 0.001x + 0.0008. 
Vitamin C content  
The vitamin C (Ascorbic acid) contents of the polyherbal remedies were determined by the 
spectrophotometric method of Njoku et al. (2015). Briefly, 1.0 g of each remedy was 
macerated with 20 mL of 0.4% oxalic acid. This was filtered using Whatman No. 1 filter 
paper. Nine of indophenol reagent was added to 1.0 mL of the filtrate. Standard solution of 
vitamin C was prepared similarly and the absorbances of the standard solutions and the 
remedies were read at 540 nm using UV-3000PC spectrophotometer. The concentrations of 
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the standard working solutions were 0.1 mg/mL, 0.2 mg/mL, 0.4 mg/mL, 0.6 mg/mL, 0.8 
mg/mL and 1.0 mg/mL respectively. The concentration of vitamin C was extrapolated from 
the standard curve of vitamin C using the following equation:  
Y = 0.67x + 0.0824 
Vitamin E content 
The vitamin E (α-tocopherol) contents of the remedies were determined using the method of 
Njoku et al. (2015). A quantity, 1.0 g of each remedy was macerated with 20 mL of ethanol 
and then filtered using Whatman No. 1 filter paper. One millilitre of 0.2% ferric chloride in 
ethanol and 1.0 mL of 0.5% α-α-dipyridine solution were added to 1.0 mL of the filtrate. The 
solution was diluted to 5.0 mL with distilled water before the absorbance was read at 520 nm 
using UV-3000PC spectrophotometer. The concentrations of standard working solutions 
ranged between 10 μg/mL and 100 μg/mL. The concentration of vitamin E in the samples was 
extrapolated from the standard curve using the equation: Y = 0.0086x - 0.0216. The vitamin 
contents were expressed as mg/100 g. 
 
Statistical analysis  
Each analysis was carried out in triplicates and the results were expressed as the mean ± SD. 
Minitab program version 17 for windows was used for the Analysis of Variance (Mintab Inc., 
Pennsylvania, USA). Statistical significance was evaluated at P ≤ 0.05. 
 
Results  
Macro nutrient compositions 
The macro nutrients detected in the polyherbal remedies include calcium, magnesium, 
sodium, potassium, nitrogen and phosphorus (Table 8.1). The results clearly indicated that 
these remedies are rich sources of macro nutrients. The level of potassium content was 
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markedly higher in EL remedy, followed by calcium and nitrogen while the least content was 
phosphorus. Calcium was the highest content found in KWTa and HBfs remedies. This was 
followed by nitrogen, potassium, sodium, magnesium and phosphorus in descending order 
respectively. Nitrogen was markedly higher in FB remedy while the nutrient found in the 
lowest level was phosphorus. KWTb and KWTc remedies contained high calcium content, 
followed by nitrogen and potassium with sodium being the lowest nutrient observed in the 
remedies. Calcium, potassium and nitrogen were the nutrients having highest values in AL, 
HBss, and HBts remedies respectively. 
However, across the herbal formulations, calcium was the nutrient with the highest values 
detected, except in EL and FB remedies were potassium and nitrogen were the highest 
respectively. However, the lowest macro nutrients in majority of the remedies were 
phosphorus and magnesium in HBts remedy (Table 8.1). 
Micro nutrient compositions 
The micro nutrients that were determined include iron, aluminium, zinc, manganese and 
copper. Iron was the highest mineral nutrient detected in KWTa, AL, HBft, HBss and HBts 
remedies. This was followed by aluminium, manganese, zinc and copper in descending order 
respectively. Also, KWTc remedy had iron as the mineral with the highest micro nutrient 
while manganese was the highest in FB remedy. The element with the highest concentration 
in EL remedy was aluminium, with copper being the mineral content with the lowest value in 
the remedy. In KWTb remedy, aluminium was the highest mineral content, followed by iron, 
manganese, zinc while the lowest was copper. In general, these polyherbal remedies are good 
sources of iron. However, the lowest micro nutrient content in all the remedies was copper.  
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Vitamin compositions  
Table 3 shows the vitamin contents in each of the polyherbal preparation. The vitamin A and 
E contents observed in the remedies vary from 95.10 to 458.20 mg/100 g and 9.00 to 9.70 
mg/100 g respectively indicating that these preparations are rich sources of retinol and α-
tocopherol. However, vitamin C content was not detected in all the herbal remedies. 
 
Discussion 
Polyherbal remedies are extensively used for the treatment and management of various 
diseases in the developing countries. According to Bhope et al. (2011) these remedies are 
mixtures of two or more medicinal herbs, which contain multiple active constituents and act 
synergistically against infections. These results have clearly indicated that the nine polyherbal 
remedies are rich sources of macro and micro nutrients. Calcium which was the highest 
mineral detected in the herbal preparations is an important mineral required in the body for the 
normal development and maintenance of the skeleton. It helps in the proper functioning of 
neuromuscular, blood clotting, nerve transmission, oocyte activation and cardiac function 
(Pravina et al., 2013). The mineral is stored in the teeth and bones where it provides structure 
and strength to the body (NHMRC, 2005; Pravina et al., 2013). Inadequate intake of this 
mineral could lead to rickets in children or osteoporosis in aging adults, particularly among 
women (IOM, 2010). 
The potassium content present in the herbal remedies was between 160.00 and 2,050.00 
mg/100g. The level of this mineral was markedly higher in EL remedy when compared with 
other polyherbal formulations. The nutrient is the major cation of intracellular fluid in the 
body, playing an important role in the synthesis of proteins and normal cell functioning such 
as digestion and neurotransmission (NHMRC, 2005). It helps to maintain the pH inside every 
cell and acts as an electrolyte, a molecule that transmits electrical activity between cells. It 
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also helps in maintaining proper nerve function and muscle contraction (Young, 2012). Thus, 
the presence of this mineral in the remedies could aid the normal cell functioning of the 
consumers considering their immunocompromised status. 
In addition, the results revealed that FB and KWTc remedies are rich in nitrogen. This 
element is required for the growth and repair of worn-out tissues (NHMRC, 2005). Also, the 
polyherbal formulations are good sources of magnesium, the nutrient that acts as a cofactor to 
more than 300 enzyme systems which regulate diverse biochemical reactions in the body 
(IOM, 1997; Rude, 2010; 2012). It is involved in many physiologic pathways such as energy 
production, oxidative phosphorylation and glycolysis. Magnesium is required for the synthesis 
of nucleic acid and antioxidant glutathione, as well as contributing to the structural 
development of the bone. This element also plays a role in the active transport of calcium and 
potassium ions across cell membranes (Rude, 2012). 
Sodium, which is a cation required to maintain extracellular fluid volume and serum 
osmolality in the body was also detected in the remedies. The nutrient plays an essential role 
in keeping the fluids and electrolytes in the body balance, transmit nerve impulses, helps in 
maintaining the membrane potential of cells and active transport of molecules across cell 
membranes (Capra, 2006). The sodium contents in these herbal formulations were between 
6.70 and 381.00 mg/100 g. The low sodium content observed in these therapies is of great 
advantage because, excessive intake of sodium in human results in arterial hypertension. This 
mineral is required in small amount; too much intake of it has been associated with increased 
risk of high blood pressure leading to heart disease, stroke and kidney disease (NHMRC, 
2005). 
The lowest macro nutrient in the majority of the remedies was phosphorus. The main 
importance of this mineral is in the formation of bones and teeth. Phosphorus, which is 
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present in smaller amounts in cells and tissues helps to filter out waste in the kidneys. It plays 
an essential role in the storage and utilization of energy in the body. The element is required 
for the growth, maintenance and repair of all tissues and cells (IOM, 1997). Also, it helps in 
the production of genetic building blocks, DNA and RNA in the body. However, since 
calcium and phosphorus are associated with each other for growth and maintenance of bones, 
teeth and muscles; the presence of calcium in the polyherbal formulations can augment for the 
low phosphorus observed. 
Also, these polyherbal remedies are good sources of iron, which is an essential component of 
a number of proteins including haemoglobin (Wessling-Resnick, 2014), myoglobin (Aggett et 
al., 2012), cytochromes and enzymes involved in redox reactions (NHRMC, 2005). It also 
plays an important role in metabolism, development, normal cellular functioning and 
synthesis of some hormones and connective tissues (Murray-Kolbe et al., 2010; Aggett et al., 
2012). The deficiency of this nutrient could increase the susceptibility of an individual to 
infection such as tuberculosis (Karyadi et al., 2000). Thus, the presence of iron in the 
polyherbal remedies is of great importance.  
Copper was the lowest mineral detected in the herbal preparations. The nutrient is one of the 
cofactors for antioxidant enzymes called superoxide dismutase in the body. It is required to 
manufacture collagen, a major structural protein in the body. It helps with incorporation of 
iron into red blood cells, prevents anaemia and involved in the generation of energy from 
carbohydrates. It is also important for nerve function, building strong tissue, bone growth, 
maintaining blood volume and helps the body in the utilization of sugar (IOM, 2001; 
NHMRC, 2005). The presences of this mineral in conjunction with other minerals detected 
could improve the immunity of the consumers. 
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Also, manganese was equally observed in the polyherbal remedies. This nutrient plays an 
important role in the formation of bone, metabolism of fat and carbohydrate, cholesterol and 
amino acids (IOM, 2001; NHMRC, 2005). It helps the body to form connective tissue, blood-
clotting factors and sex hormones. Manganese, a component of the antioxidant enzyme which 
helps to fight free radicals also plays a role in calcium absorption and blood sugar regulation 
(IOM, 2001). 
Zinc is another important micro nutrient playing a significant role in the immune system of an 
individual and helps to protect the cells against various free radicals. While some of these 
herbal formulations had low zinc level, three of the remedies namely; EL, AL and HBss were 
rich in zinc. The importance of this element cannot be ignored as it is involved in various 
functions such as cellular metabolism, catalytic activity of enzymes, protein synthesis, wound 
healing, DNA synthesis and cell division. The deficiency of Zn can leads to impairment of 
immunity and thus increases susceptibility to infections such as TB (Ramakrishnan et al., 
2008; Muthuraj et al., 2010). 
Vitamins are important in the body. They help to maintain the physiology of the body and 
boost the immune system. In this study, vitamin A had the highest concentrations followed by 
vitamin E. However, vitamin C was not detected in any of the remedies. While Vitamin A 
supports the vision and bone growth in the body, vitamin E strengthens the immune system 
and repairs the DNA (Martini et al., 2010), Vitamin E is an anti-oxidant capable of playing the 
role of vitamin C in cavity healing in active cavitary tuberculosis (Chakraborty et al., 2014).  
The supplementation of vitamin E and selenium reduces oxidative stress and enhances total 
antioxidant status in patients with pulmonary TB treated with standard chemotherapy 
(Seyedrezazadeh et al., 2008). This vitamin also helps in preventing the peroxidation of 
membrane phospholipids and cell membrane oxidation through its anti-oxidant properties 
(Njoku et al., 2015). 
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These vitamin and mineral constituents play important roles in the treatment of tuberculosis 
and also serve as cofactors for many physiologic and metabolic functions (Safarian et al., 
1989). According to SANDH (2001), patients of TB requires multivitamin and mineral 
supplement which provides about 50 to 150% of the recommended daily allowance.  
 
Conclusion 
The findings of this study indicated that these polyherbal medicines are rich sources of 
vitamins and essential nutrients. Considering the amount of vitamins and mineral constituents 
in the polyherbal preparation, it could be deduced that these remedies are probably boosting 
the immune system of TB patients thereby aiding their recovery. 
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Table 8.1: Macro nutrient compositions (mg/100 g) of nine polyherbal remedies used for the treatment of tuberculosis in the Eastern Cape 
Province, South Africa 
Sample N Ca Mg Na K P 
EL 803.30 ± 0.08ac   1956.70 ± 0.02ae   406.70 ± 0.02a 381.66 ± 8.20a 2050 ± 0.20a   263.33 ± 5.77a 
KWTa 626.70 ± 0.16bd  2113.30 ± 0.89a   160.00 ± 0.04b   184.25 ± 64.58b 483.33 ± 0.11b   76.67 ± 25.17b 
AL 713.30 ± 0.03bc   973.30 ± 0.02b   216.67 ± 0.00c   362.57 ± 5.99a 806.67 ± 0.01c   146.67 ± 5.77c 
HBfs 583.30 ± 0.05bd  1376.70 ± 0.09bc  80.00 ± 0.01d  300.59 ± 9.07c 373.33 ± 0.03b   73.33 ± 15.28b 
HBss 590.00 ± 0.03bd   1363.30± 0.11bc  156.67 ± 0.01b   113.25 ± 10.81d 760.00 ± 0.05c   123.33 ± 5.77c 
HBts 903.30 ± 0.07ae 2180.00 ± 0.03a 110.00 ± 0.00e   201.57 ± 10.92b 970.00 ± 0.04d   143.33 ± 5.77c 
FB 1866.70 ± 0.08f   1120.00 ± 0.02bc   260.00 ± 0.00f  276.27 ± 5.59c 1660.00 ± 0.04e   200.00 ± 10.00d 
KWTb 560.00 ± 0.03d   1567.00 ± 0.21ce  140.00 ± 0.01b  20.52 ± 1.34e 160.00 ± 0.03f   46.67 ± 5.77f 
KWTc 1023.30 ± 0.08e   6503.30 ± 0.07d 76.67 ± 0.00d   6.73 ± 0.02e 200.00 ± 0.01f   20.00 ± 0.00e 
 
King Williams Town site A (KWTa), King Williams Town site B (KWTb), King Williams Town site C (KWTc), Hogsback first site (HBfs), Hogsback 
second site (HBss), Hogsback third site (HBts), East London (EL), Alice (AL) and Fort Beaufort (FB). 
Each value represents the mean ± standard deviation for triplicate determinations. Different superscripts within the same column are significantly different 
(P≤ 0.05). 
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Table 8.2: Micro mineral compositions (mg/100 g) of nine polyherbal remedies used for the 
treatment of tuberculosis in the Eastern Cape Province, South Africa 
Sample Zn Cu Mn Fe Al 
EL 8.13 ± 0.65a 1.31 ± 0.11a 6.70 ± 1.60a 112.70 ± 48.54a 158.70 ± 69.57a 
KWTa 1.70 ± 0.56b 0.61 ± 0.44b 39.13 ± 14.75b 54.6 ± 38.54b 39.87± 23.09b 
AL 3.03 ± 0.12c 0.56 ± 0.04b 7.43 ± 0.15a 35.57 ± 1.04bc 30.50 ± 0.85 b 
HBfs 0.90 ± 0.05d 0.19 ± 0.01c 8.57 ± 0.37a 24.63 ± 15.91bc 11.8 ± 0.70 b 
HBss 3.03 ± 0.35c 0.51 ± 0.09bd 3.40 ± 0.20a 18.93 ± 5.21bc 13.07 ± 1.40 b 
HBts 2.17 ± 0.12b 0.56 ± 0.18b 5.37 ± 0.12a 20.17 ± 4.38bc 17.97 ± 1.85 b 
FB 2.17 ± 1.49b 0.67 ± 0.19b 18.67 ± 0.29c 14.70 ± 1.18c 15.07 ± 1.04 b 
KWTb 0.70 ± 0.02de 0.25 ± 0.04cd 23.77 ± 2.79c 32.67 ± 4.15bc 45.57 ± 5.84 b 
KWTc 0.30 ± 0.17e 0.25 ± 0.03cd 58.03 ± 2.49d 76.50 ± 30.20bc 44.30 ± 0.06 b 
 
King Williams Town site A (KWTa), King Williams Town site B (KWTb), King Williams Town site C 
(KWTc), Hogsback first site (HBfs), Hogsback second site (HBss), Hogsback third site (HBts), East 
London (EL), Alice (AL) and Fort Beaufort (FB). Data expressed as mean ± SD of three replicates. 
Different superscripts within the same column are significantly different (P≤ 0.05). 
 
 
 
 
 
 
 
 
 
120 
 
Table 8.3: Vitamin contents (mg/100g) detected in nine polyherbal remedies used for the 
treatment of tuberculosis in the Eastern Cape Province, South Africa 
Sample Vitamin A  Vitamin E  
EL 459.20 ± 0.02a  9.40 ± 0.01ae   
KWTa 262.20 ± 0.02b 9.50 ± 0.02ab   
AL 124.80 ± 0.02c 9.0 ± 0.02cd   
HBfs 197.00 ± 0.00d 9.50 ± 0.01bd   
HBss 200.80 ± 0.00d 9.30 ± 0.03e 
HBts 333.10 ± 0.02e 9.40 ± 0.01e   
FB 365.40 ± 0.00e 9.00 ± 0.03f   
KWTb 201.80 ± 0.00d 9.70 ± 0.05c 
KWTc 96.10 ± 0.01c 9.30 ± 0.04e 
 
Data expressed as mean ± SD of three replicates. Different superscripts within the same column are 
significantly difference (P≤ 0.05). 
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General Discussion 
Tuberculosis has remained a serious threat to human health, with about one-third of the 
global population infected. Despite the development of anti-tubercular agents, millions of 
people are still suffering and dying from the disease. In 2015, about 10.4 million new cases of 
tuberculosis were reported worldwide, out of which 1.4 million deaths were recorded (WHO, 
2016). Due to non-compliance of patients to the use of TB-drugs, poor access to TB-drugs, 
the rise in drug resistance, nature of the lipid-rich cell wall of TB, coupled with the 
association with HIV infection have worsened the global situation of tuberculosis; thus 
difficult to control (Kumar et al., 2017). 
In the developing countries, cases of tuberculosis infection are rampant in low-income 
countries like South-East Asia and Africa. It was estimated that in every 100,000 people 
living in Sub-Saharan Africa, 350 are infected (WHO, 2016). South Africa is one of the six 
countries with the highest burden of tuberculosis, HIV-associated TB and the second highest 
number of diagnosed multidrug-resistant TB cases (Churchyard et al., 2014). With the 
continuing global epidemic of tuberculosis, coupled with the resistance of this organism to 
anti-tubercular agents, there is a need to develop new drugs from the herbal origin (Bhatcha, 
2013). 
The use of herbal medicines for the treatment and management of various illnesses has 
increased tremendously in the developed and developing countries. It was estimated that 
about 80% of the population in the developing countries make use of traditional medicine for 
their primary health care (WHO, 2002). The use of modern medicine in the treatment of 
complex disease such as tuberculosis is associated with the problem of cross-resistance. 
However, herbal drugs often produce a promising effect in this context over a single purified 
drug (Mehta et al., 2015; Aslam et al., 2016). Many medicinal plants have been reported in 
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different parts of the world to possess anti-tubercular activity. These plants often contain 
phytoconstituents such as alkaloids, tannins, flavonoids, xanthones, triterpenes and quinines 
which are involved in the anti-tubercular activity (Arya, 2011; Bhatcha, 2013). Medicinal 
plants used in combination as polyherbal formulations have shown to have potential 
interactive effects which usually produced maximum benefit and effective therapeutic 
purpose (Nadeem et al., 1996). Some of these effects include mutual enhancement, mutual 
assistance, mutual restraint and mutual antagonism (Ramaiah et al., 2013). 
In South Africa, about 72% of the black African population use herbal medicines for their 
health needs (Mander et al., 2007). Studies have shown that the people living in the Eastern 
Cape Province make use of herbal medicines for the treatment of tuberculosis and associated 
diseases (Buwa and Afolayan, 2009; Lawal et al., 2014). However, there is no information on 
the documentation of the polyherbal medicines used for the treatment of tuberculosis in the 
Province, as well as the scientific evidence to justify the ethno-medicinal use and guarantee 
the safety of the consumers. 
Ethno-medicinal documentation of polyherbal medicines used for the treatment of 
tuberculosis  
The indigenous knowledge of herbal medicines in many parts of the world is fast 
disappearing due to the transformation of traditional culture (Hussain et al., 2010). The 
survey carried out in this project showed that nine polyherbal medicines made from 24 plant 
species, belonging to 20 families are used for the treatment of tuberculosis in the study area 
(Chapter 2). While the frequently mentioned plant families are Apiaceae, Liliaceae, 
Strychnaceae, Rutaceae and Hypoxidaceae; the four most commonly used plants are Allium 
sativum L. (Liliaceae), Strychnos decussata (Pappe) Gilg. (Strychnaceae), Daucus carota L. 
(Apiaceae) and Hypoxis argentea (Fiscand) (Hypoxidaceae). The therapeutic claims made on 
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most of the medicinal plants used for the preparation of these remedies are well supported by 
the literature, with many of the species having antimicrobial properties (Buwa and Afolayan, 
2009; Bisi-Johnson et al., 2010; Green et al., 2010). The documentation of ethno-medicinal 
information has a significant role in illuminating folk knowledge, which facilitates the 
discovery of modern allopathic drugs (Flaster, 1996; Cox, 2000; Rashid and Arshad, 2002). 
In order to preserve the loss of traditional knowledge of polyherbal medicines, it is necessary 
that inventories of plants, part used, mode of preparation and the dosage used are properly 
documented in systematic studies. This survey helps in the conservation of indigenous 
knowledge through the identification of polyherbal medicines used for the treatment of 
tuberculosis with market potential that can generate incomes for local communities. The 
knowledge also provides useful leads for scientific research, especially in the development of 
modern allopathic drugs destined for the international markets (Ismail and Nisar, 2010). 
Molecular identification of bacterial and fungal contaminants of the polyherbal 
medicines  
In order to guarantee the safety of the consumers, it is important to identify various bacteria 
and fungi present in the polyherbal medicines (Chapter 3 and 4). Several investigations have 
shown that herbal medicines are associated with a broad variety of contaminants such as 
microbial agents and heavy metals (Ting et al., 2013; Noor et al., 2014; Anyanwu, 2010; 
Osei-Adjei et al., 2013). Both pathogenic and non-pathogenic bacteria, as well as fungi 
contaminants particularly moulds and yeast, were identified in the herbal preparations. Some 
of the identified bacteria that are clinically pathogenic to human include Raoultella 
ornithinolytica, Rahnella aquatilis, Bacillus anthracis, Bacillus cereus, Salmonella enteric, 
Enterobacter cloacae, Klebsiella oxytoca and Klebsiella pneumonia. Others such as 
Enterobacter asburiae, Paenibacillus polymyxa, Pantoea rwandensis, Klebsiella variicola 
and Pseudomonas sp. are opportunistic pathogens causing opportunistic infections in 
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individuals with impaired immunity. The predominant mycoflora obtained include 
Alternaria, Candida, Ramularia, Cladosporium, Penicillium, Aspergillus and Malassezia. 
While some of these organisms are capable of producing mycotoxins, others could cause 
infections in immunocompromised patients. Different factors such as temperature, humidity 
and extent of rainfall during pre-harvesting and post-harvesting periods, handling practices, 
unhygienic production conditions and storage period could have influenced the contamination 
of these remedies (De Freitas Araújo et al., 2012). The presence of these microbial 
contaminants in the polyherbal remedies is of great concern, considering the 
immunocompromised status of the consumers. 
Antimicrobial activity of the polyherbal medicines 
Tuberculosis medications have been revolutionized due to the resistant strain of 
Mycobacterium tuberculosis, thus, there is a need to develop alternative medicines using 
medicinal plants. Many studies have shown that medicinal plants possess antimicrobial 
activity (Afolayan and Meyer, 1997; Buwa and Afolayan, 2009; Askun et al., 2012). They 
play a significant role in the process of drug discovery and development, as many infectious 
diseases have been treated by them (Newman and Cragg, 2007; Mativandlela, et al., 2008; 
Gupta et al., 2010). The effect of the polyherbal remedies on Mycobacterium tuberculosis as 
well as on opportunistic bacterial and fungal pathogens associated with tuberculosis infection 
was examined (Chapter 5 and 6). Seven of the herbal preparations showed greater anti-
mycobacterial activity. This is an indication that these remedies could be potential sources of 
new anti-tubercular agents (Chapter 5). Only three preparations showed activity against Gram 
positive and negative bacteria. However, KWTa remedy showed activity against Aspergillus 
spp. while KWTc and HBts had the highest activity against Candida albicans (Chapter 6). 
The capability of these remedies to inhibit the organisms is an indication that they are 
potential broad-spectrum antimicrobial agents.  
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Toxicological evaluation of the polyherbal medicines 
There is a perception that herbal medicines are generally safe, bio-friendly, eco-friendly and 
free from side effects. However, studies have shown that some of them are known to carry 
toxicological properties (Hamidi et al., 2014). According to Calixto (2000), the general idea 
that herbal medicines are completely safe and free from side effects because they come from 
natural origin is false. Not all of the herbal preparations reported to be useful are harmless 
because they contain biologically active chemical substances. Thus, in order to ensure the 
safety of the users, polyherbal medicines used for the treatment of tuberculosis in the study 
area were screened for toxicity using the Brine shrimp toxicity assay (Chapter 7). The herbal 
preparations exhibited low toxicity on the hatching success of A. salina cysts and on the 
mortality of the larvae. This is an indication that the polyherbal formulations are non-toxic, 
thus, they could be safe for consumption. However, further in vivo toxicity tests are required 
to validate the safety of the users. 
Evaluation of some important vitamins and mineral nutrients of the herbal medicines 
Vitamins and mineral nutrients are essential and are needed for normal growth and 
maintenance of body functions. While vitamins are responsible for a spectrum of vital 
functions in the body, the mineral nutrients work together for tissue regeneration, cellular 
integrity and play important roles in the treatment of tuberculosis (Gupta et al., 2009). Herbal 
medicines are believed to contain pharmacological properties capable of boosting the 
immunity of TB-infected patients and aid quick recovery. Thus, some important vitamins and 
mineral nutrients in polyherbal medicines used for the treatment of tuberculosis were 
evaluated (Chapter 8). The remedies are rich sources of vitamins A, E and essential nutrients. 
It could be deduced that these remedies are probably boosting the immune system of 
tuberculosis patients thereby aiding their recovery. 
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Conclusions   
This study has provided significant ethno-medicinal information on polyherbal medicines 
used for the treatment of tuberculosis in the Eastern Cape Province, South Africa. This 
information will preserve the traditional culture of the people by preventing the loss of 
indigenous knowledge of polyherbal preparations. The identification of bacteria and fungi in 
the polyherbal medicines is a great concern. Although, the majority of the microorganisms 
are non-pathogenic; however, they are capable of causing infections in tuberculosis patients, 
considering their immunocompromised status. The study suggests that government should 
take adequate control measures to set specific standards for quality of these medicines. The 
ability of the remedies to possess activity against Mycobacterium tuberculosis and their effect 
on the organisms capable of causing secondary infections in tuberculosis patients gives 
confidence to their therapeutic usage as anti-Mycobacterium tuberculosis. Also, the 
toxicological evaluation of the remedies indicated that they are safe for consumption. The 
presence of vitamins, macro and micro nutrients in the herbal preparations support their 
folkloric use as they can serve as dietary supplements boosting the immune system of the 
tuberculosis patients. The findings of this study provide scientific validation of the use of 
polyherbal medicines in the treatment of tuberculosis and associated diseases in the Eastern 
Cape Province of South Africa. 
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Contributions to knowledge  
1. The study is the first to have documented the list of ingredients such as the name of 
the plants including the non-herbal inclusions, type and dosage of polyherbal 
formulations used for the treatment of tuberculosis in South Africa. This might help in 
preventing the loss of indigenous knowledge on the preparation of polyherbal 
medicines used for the treatment of tuberculosis.  
2. The study successfully identified bacterial and fungal contaminants in the polyherbal 
remedies. This will help in creating awareness to the herbal healers and the consumers 
that proper hygienic condition is required during the preparation stages and the 
storage period.  The study has shown that there is a need for government to take 
adequate control measures to set specific standards for quality of these medicines 
considering the immunocompromised status of the consumers. 
3. The study has further provided scientific insight by showing the herbal remedies as 
possible anti-tubercular agents. This could also provide useful leads in the 
development of modern allopathic drugs that will solve the problem of multi-drug 
resistant tuberculosis. 
4. The toxicity assay carried out has shown that the remedies are safe for consumption; 
however, further in vivo analysis is required.  
5. Also, the study has further revealed the nutritive properties of the polyherbal 
medicines, thus, suggesting that they could probably help in boosting the immune 
system of tuberculosis patients thereby aiding their recovery.  
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Main purpose of the research 
To collect information from the herbal healers regarding the use of polyherbal medicines 
used for the treatment of tuberculosis. 
 
Objectives of the research  
To investigate and document the list of ingredients such as the name of the plants used 
including the non-herbal inclusions, type, mode of preparation and dosage of polyherbal 
formulations used for the treatment of tuberculosis. 
 
 
 
